<SEC-DOCUMENT>0001193125-15-134248.txt : 20150417
<SEC-HEADER>0001193125-15-134248.hdr.sgml : 20150417
<ACCEPTANCE-DATETIME>20150417070130
ACCESSION NUMBER:		0001193125-15-134248
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20150417
FILED AS OF DATE:		20150417
DATE AS OF CHANGE:		20150417

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NOVOGEN LTD
		CENTRAL INDEX KEY:			0001075880
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-29962
		FILM NUMBER:		15776492

	BUSINESS ADDRESS:	
		STREET 1:		LEVEL 1
		STREET 2:		16 - 20  EDGEWORTH DAVID AVE
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
		BUSINESS PHONE:		01161298780088

	MAIL ADDRESS:	
		STREET 1:		LEVEL 1
		STREET 2:		16 - 20  EDGEWORTH DAVID AVE
		CITY:			HORNSBY NSW
		STATE:			C3
		ZIP:			2077
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d911894d6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 6-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>Form 6-K
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REPORT OF FOREIGN PRIVATE ISSUER </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PURSUANT TO RULE 13a-16 OR 15d-16 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNDER THE SECURITIES EXCHANGE ACT OF 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>For the month of April, 2015 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Commission File Number
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>Novogen
Limited </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Translation of registrant&#146;s name into English) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>16-20 Edgeworth David Ave, Hornsby, NSW 2077, Australia </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive office) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether
the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Form 20-F&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Form 40-F&nbsp;&nbsp; <FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&nbsp;&nbsp;<FONT
STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted
solely to provide an attached annual report to security holders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as
permitted by Regulation S-T Rule 101(b)(7):&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Note</B>: Regulation S-T Rule 101(b)(7) only
permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated,
domiciled or legally organized (the registrant&#146;s &#147;home country&#148;), or under the rules of the home country exchange on which the registrant&#146;s securities are traded, as long as the report or other document is not a press release, is
not required to be and has not been distributed to the registrant&#146;s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission
pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT>&nbsp;&nbsp;&nbsp;&nbsp; No&nbsp;&nbsp;<FONT STYLE="FONT-FAMILY:WINGDINGS">&#254;</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If &#147;yes&#148; is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b) </P>
<P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Novogen Limited </B>(Registrant) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Lionel Mateo </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Lionel Mateo </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Company Secretary </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date 17&nbsp;April 2015 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g911894g68q31.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="29%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="12%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="55%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ASX:NRT</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NASDAQ:NVGN</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Ltd</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(Company)</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">ABN 37 063 259 754</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Capital Structure</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ordinary Shares on issue:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">276 M</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Board of
Directors</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Dr Graham Kelly</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chairman &amp; Executive Director</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Steve Coffey</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non Executive Director</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>John O&#146;Connor</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Non Executive Director</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Prof Peter Gunning</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Non Executive Director</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>MARKET RELEASE</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">17&nbsp;April
2015</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOVOGEN AND FEINSTEIN INSTITUTE JOIN FORCES TO FIND EFFECTIVE
TREATMENTS FOR BRAIN CANCER</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt" align="left">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B></B><B>TRXE-009 distinguished by ability to kill chemo-resistant adult
and paediatric brain cancer cells</B></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.50em; font-size:10pt; font-family:Times New Roman">&#149;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Studies to optimize delivery of TRXE-009 to brain cancer tissue</B></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>17 April 2015. Sydney AUSTRALIA</B>: US-Australian drug discovery company, Novogen,
today announced that it had signed a Memorandum of Understanding with the Feinstein Institute for Medical Research (&#145;Feinstein Institute&#146;) of New York to collaborate with the objective of developing effective treatments for brain
cancers.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The collaboration brings together the drug discovery expertise of Novogen and
the preclinical and clinical expertise of the Feinstein Institute in neurosciences and oncology.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">At the heart of the collaboration is the Company&#146;s super-benzopyran (SBP) drug technology platform, distinguished by its ability to kill the full spectrum
of cells within a tumor including both rapidly- and slowly-dividing cancer cells (tumor-initiating cells).</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The three key areas of research will be:</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the development of lead SBP drug candidate, TRXE-009, as a treatment of both primary
and secondary brain cancer in adults and children, including glioblastoma and medulloblastoma;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the potential ability of the SBP technology (based on early evidence) to deliver an
entirely novel approach to chemotherapy by converting cancer stem cells into stem cells displaying normal stem cell behaviour;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:2.00em; text-indent:-2.00em; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the development of drug candidates as radio-sensitizers designed to augment the
effectiveness of radiotherapy in treating brain cancers.</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRXE-009 (Trilexium) is a
pan-acting (across all forms of cancer) anti-cancer cytotoxic molecule that is on track to enter the clinic in early-2016 for the treatment of solid and non-solid cancers. A particularly high activity against melanoma cells has been announced
previously and malignant melanoma is expected to be a key clinical indication to be pursued. For this purpose, TRXE-009 will be delivered systemically in a way that the Company has confirmed in animal studies delivers the drug in a bio-available
form in the bloodstream that delivers a potent anti-tumor effect on tumors growing outside of the brain. The task now remains to confirm that TRXE-009 can be delivered to brain cancer tissue in adequate amounts.</P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">TRXE-009 has proven to be particularly effective in vitro against adult (glioblastoma) and
paediatric (diffuse intrinsic pontine glioma; medulloblastoma) brain cancer cells, marking it as a unique and highly promising drug candidate for the treatment of these cancers. The collaboration announced today is focused specifically on these
tumors and the need to optimize the delivery of TRXE-009 to cancerous tissue within the brain.</P></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g911894g31b33.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g911894g80l95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen CEO Graham Kelly, PhD, said today, &#147;We are confident that we have found the drug that can successfully treat
cancers arising in the brain as well as cancers that spread to the brain from elsewhere. The ability of TRXE-009 to kill brain cancer stem-like cells gives us particular confidence that we can finally kill off the root cause of any cancer within the
brain.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;The proviso is that we can deliver it across the blood-brain barrier, and that is something that we will not know with any certainty
until we bring TRXE-009 into the clinic. The collaboration with the Feinstein Institute is designed to maximize that likelihood. If we can do that, then we have a good chance of delivering breakthrough treatment options to adults and children with
primary brain cancers and for patients with cancers such as melanoma that involve the brain and elsewhere,&#148; added Kelly. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Using models developed in
the laboratory by the Feinstein Institute, the ability of TRXE-009 to treat various forms of human brain cancer will be studied using a variety of new approaches, such as direct microinjection into the brain (convection enhanced delivery) and
intravenous administration with a range of constructs known to facilitate the transport of drugs across the blood-brain barrier, some of which have been developed by Novogen chemists. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;This collaboration between the Feinstein Institute and Novogen is critical to supporting the discovery of new treatments for patients who suffer from
life-threatening brain cancer,&#148; said John A. Boockvar, MD, who co-directs the Feinstein Institute&#146;s Brain Tumor Biotech Center with Marc Symons, PhD. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">&#147;Patients who suffer from brain cancer don&#146;t have optimal therapies to turn to. By offering them new, improved treatments, we will give hope to
patients who face a devastating disease.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Super-Benzopyrans and TRXE-009 </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Super-benzopyrans (SBPs) are small molecules based on an expanded benzopyran molecular structure. They display pleiotropic biological properties involving both
pro-survival and pro-death functions based on particular structural properties. TRXE-009 has been selected for its cytotoxicity against cancer cells. The mechanism of action is not fully elucidated and multiple molecular targets are thought to be
involved, including gene transcription factors. Inhibition of ion exchange mechanisms leading to loss of trans-membrane potential is a known target. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About The Feinstein Institute for Medical Research </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Headquartered in Manhasset, NY, The Feinstein Institute for Medical Research is home to international scientific leaders in many areas including cancer,
Parkinson&#146;s disease, Alzheimer&#146;s disease, psychiatric disorders, rheumatoid arthritis, lupus, sepsis, human genetics, pulmonary hypertension, leukemia, neuroimmunology, and medicinal chemistry. The Feinstein Institute, part of the North
Shore-LIJ Health System, ranks in the top 6th percentile of all National Institutes of Health grants awarded to research centers. For more information, visit <U>www.FeinsteinInstitute.org</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About brain cancers </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cancers of the brain can be divided
into those that originate within the brain (primary brain cancers) and those that originate outside of the brain (secondary or metastatic brain cancers); lung cancer and melanoma are common causes of secondary brain cancers. The most common type of
primary brain cancer in adults is glioblastoma and in children is medulloblastoma. Treatment options involve surgery, radiotherapy and chemotherapy. Chemotherapy options are limited by two main factors: (1) the poor sensitivity of brain cancer cells
to chemotherapy drugs; and (2) the difficulty of transporting drugs to the brain across the blood-brain barrier. Only 1 in 5 adults diagnosed with malignant brain cancer will survive for at least 5 years. In the US and Australia, survival rates have
improved less than 2% over the past 30 years. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g911894g31b33.jpg" ALT="LOGO">
 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g911894g80l95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Novogen Limited </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen is a public, Australian-US drug-development company whose shares trade on both the Australian Securities Exchange (&#145;NRT&#146;) and NASDAQ
(&#145;NVGN&#146;). The Novogen group includes US-based, CanTx Inc, a joint venture company with Yale University. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen has two main drug technology
platforms: super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). SBP compounds have been designed to kill the full heterogeneity of cells within a tumor, but with particular activity against the cancer stem (tumor-initiating) cell. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The ATM compounds target the micro-filament component of the cancer cell&#146;s cytoskeleton and have been designed to combine with anti-microtubule drugs
(taxanes, vinca alkaloids) to produce comprehensive and fatal destruction of the cancer cell cytoskeleton. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company pipeline comprises two SBP drug
candidates (TRXE-002, TRXE-009) and one ATM drug candidate (<I>Anisina</I>). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Further information is available on our website <U>www.novogen.com</U> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For more information please contact: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="51%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Contact</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dr. Graham Kelly</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Executive Chairman &amp; CEO</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Group</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Graham.Kelly@novogen.com</U></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">+61 (0) 2 9472 4100</P></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Media Enquiries</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Cristyn Humphreys</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Chief Operating Officer</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Novogen Group</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>Cristyn.Humphreys@novogen.com</U></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">+61 (0) 2 9472
4111</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Forward Looking Statement </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>This press release contains &#147;forward-looking statements&#148; within the meaning of section 27A of the Securities Act of 1933 and section 21E of the
Securities Exchange Act of 1934.&nbsp;The Company has tried to identify such forward-looking statements by use of such words as &#147;expects,&#148; &#147;appear,&#148; &#147;intends,&#148; &#147;hopes,&#148; &#147;anticipates,&#148;
&#147;believes,&#148; &#147;could,&#148; &#147;should,&#148; &#147;would,&#148; &#147;may,&#148; &#147;target,&#148; &#147;evidences&#148; and &#147;estimates,&#148; and other similar expressions, but these words are not the exclusive means of
identifying such statements.&nbsp;Such statements include, but are not limited to any statements relating to the Company&#146;s drug development program, including, but not limited to the initiation, progress and outcomes of clinical trials of the
Company&#146;s drug development program, including, but not limited to, </I><I>TRXE-009</I><I>, and any other statements that are not historical facts.&nbsp;Such statements involve risks and uncertainties, including, but not limited to, those risks
and uncertainties relating to the difficulties or delays in financing, development, testing, regulatory approval, production and marketing of the Company&#146;s drug components, including, but not limited to </I><I>TRXE-009</I><I>, the ability of
the Company to procure additional future sources of financing, unexpected adverse side effects or inadequate therapeutic efficacy of the Company&#146;s drug compounds, including, but not limited to, </I><I>TRXE-009</I><I>, that could slow or prevent
products coming to market, the uncertainty of patent protection for the Company&#146;s intellectual property or trade secrets, including, but not limited to, the intellectual property relating to </I><I>TRXE-009</I><I>, and other&nbsp;risks detailed
from time to time in the filings the Company makes with Securities and Exchange Commission including its annual reports on Form 20-F and its reports on Form 6-K.&nbsp;Such statements are based on management&#146;s current expectations, but actual
results may differ materially due to various factions including those risks and uncertainties mentioned or referred to in this press release.&nbsp;Accordingly, you should not rely on those forward-looking statements as a prediction of actual future
results.</I> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g911894g31b33.jpg" ALT="LOGO">
 </P>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g911894g31b33.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g911894g31b33.jpg
M_]C_X03817AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``"OR````G$``*_(```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-3HP,SHP-B`Q,SHU-CHS.0```Z`!
M``,````!``$``*`"``0````!```"RZ`#``0````!````/0`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```.B`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`#@"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`],),G4\J+[65M+['AC!R
MYQ@*1Y/Q5?-]`XY&3(JD21,S^;]#W)*-UHCMZMAL:2VW41!<'!NI_>A#=E7V
MM#FV0TZ@LT!']8(.SI>TEC_"`>>?Y358;MV-V_1C3X?-.T8_6=Z']UKDV_O.
M/]H_WIM[_P!YW^<?[U8/I]X^7^Q0(K_>^]);2-MUS/HV.'S)'XJQCY%]E@8[
M4$'42.$`;>T?+E&PW%UXEI;`/TH\/Y+G)%,;L;MP-?()/XJ<GQ*9)-95Y/B4
MQ)CDI))*8R[Q*!D&0TDD1/<C^*.YSA(#"?,D`?\`?G*IE.K(:,AD"3L+7:_R
MNR(1(Z-:UT/_`$;B!&NTF)4=[_WW?YQ_O1'5XY$LM(\GM/\`U3$(B#$@^8F/
MQA.83:G%SA#G.(\R?[U&NNMMK7N+W-:=6;W%IT_=>5-C6N/N<&#X$_D1FLPQ
M]*PD^0(_@DBA8NOJGP\JO)-C:2X&H@.#I$?2B/\`-5QLR)).H5'IOV$&\8DN
M?N'K%TS/NV_3#6_O_05X<CXA-.^C/&Z'%5^#_]G_[0SV4&AO=&]S:&]P(#,N
M,``X0DE-!"4``````!``````````````````````.$))300Z``````$7````
M$`````$```````MP<FEN=$]U='!U=`````4`````4'-T4V)O;VP!`````$EN
M=&5E;G5M`````$EN=&4`````0VQR;0````]P<FEN=%-I>'1E96Y":71B;V]L
M``````MP<FEN=&5R3F%M951%6%0````:`%P`7`!3`$X`1P!&`$(`50`M`$T`
M5P!3`"T`1@!0`#$`,`!<`&(`<P!I`%\`<`!R`#,```````]P<FEN=%!R;V]F
M4V5T=7!/8FIC````#`!0`'(`;P!O`&8`(`!3`&4`=`!U`'````````IP<F]O
M9E-E='5P`````0````!";'1N96YU;0````QB=6EL=&EN4')O;V8````)<')O
M;V9#35E+`#A"24T$.P`````"+0```!`````!```````2<')I;G1/=71P=71/
M<'1I;VYS````%P````!#<'1N8F]O;```````0VQB<F)O;VP``````%)G<TUB
M;V]L``````!#<FY#8F]O;```````0VYT0V)O;VP``````$QB;'-B;V]L````
M``!.9W1V8F]O;```````16UL1&)O;VP``````$EN=')B;V]L``````!"8VMG
M3V)J8P````$```````!21T)#`````P````!29"`@9&]U8D!OX```````````
M`$=R;B!D;W5B0&_@````````````0FP@(&1O=6)`;^````````````!"<F14
M56YT1B-2;'0```````````````!";&0@56YT1B-2;'0```````````````!2
M<VQT56YT1B-0>&Q`4@````````````IV96-T;W)$871A8F]O;`$`````4&=0
M<V5N=6T`````4&=0<P````!09U!#`````$QE9G15;G1&(U)L=```````````
M`````%1O<"!5;G1&(U)L=````````````````%-C;"!5;G1&(U!R8T!9````
M````````$&-R;W!7:&5N4')I;G1I;F=B;V]L``````YC<F]P4F5C=$)O='1O
M;6QO;F<`````````#&-R;W!296-T3&5F=&QO;F<`````````#6-R;W!296-T
M4FEG:'1L;VYG``````````MC<F]P4F5C=%1O<&QO;F<``````#A"24T#[0``
M````$`!(`````0`"`$@````!``(X0DE-!"8```````X`````````````/X``
M`#A"24T$#0``````!````'@X0DE-!!D```````0````>.$))30/S```````)
M```````````!`#A"24TG$```````"@`!``````````(X0DE-`_4``````$@`
M+V9F``$`;&9F``8```````$`+V9F``$`H9F:``8```````$`,@````$`6@``
M``8```````$`-0````$`+0````8```````$X0DE-`_@``````'```/______
M______________________\#Z`````#_____________________________
M`^@`````_____________________________P/H`````/______________
M______________\#Z```.$))300````````"``$X0DE-!`(```````0`````
M.$))300P```````"`0$X0DE-!"T```````8``0````(X0DE-!`@``````!``
M```!```"0````D``````.$))300>```````$`````#A"24T$&@`````#.P``
M``8``````````````#T```++`````P`P`#``,@````$`````````````````
M`````````0`````````````"RP```#T``````````````````````0``````
M```````````````````0`````0```````&YU;&P````"````!F)O=6YD<T]B
M:F,````!````````4F-T,0````0`````5&]P(&QO;F<``````````$QE9G1L
M;VYG``````````!"=&]M;&]N9P```#T`````4F=H=&QO;F<```++````!G-L
M:6-E<U9L3',````!3V)J8P````$```````5S;&EC90```!(````'<VQI8V5)
M1&QO;F<`````````!V=R;W5P241L;VYG``````````9O<FEG:6YE;G5M````
M#$53;&EC94]R:6=I;@````UA=71O1V5N97)A=&5D`````%1Y<&5E;G5M````
M"D53;&EC951Y<&4`````26UG(`````9B;W5N9'-/8FIC`````0```````%)C
M=#$````$`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O
M;6QO;F<````]`````%)G:'1L;VYG```"RP````-U<FQ415A4`````0``````
M`&YU;&Q415A4`````0```````$US9V5415A4`````0``````!F%L=%1A9U1%
M6%0````!```````.8V5L;%1E>'1)<TA434QB;V]L`0````AC96QL5&5X=%1%
M6%0````!```````):&]R>D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX`
M```'9&5F875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E<G1!;&EG
M;@````=D969A=6QT````"V)G0V]L;W)4>7!E96YU;0```!%%4VQI8V5"1T-O
M;&]R5'EP90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/
M=71S971L;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H
M=$]U='-E=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$
M%```````!`````(X0DE-!`P``````[X````!````H`````X```'@```:0```
M`Z(`&``!_]C_[0`,061O8F5?0TT``?_N``Y!9&]B90!D@`````'_VP"$``P(
M"`@)"`P)"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,
M$1$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(``X`
MH`,!(@`"$0$#$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&
M!P@)"@L!``$%`0$!`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'
M!@@%`PPS`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R62
M4_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3T
MI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&
M!34!``(1`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E
M!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E
M]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/3"3)U/*B^U
ME;2^QX8P<N<8"D>3\57S?0..1DR*I$D3,_F_0]R2C=:([>K8;&DMMU$07!P;
MJ?WH0W95]K0YMD-.H+-`1_6"#LZ7M)8_P@'GG^4U6&[=C=OT8T^'S3M&/UG>
MA_=:Y-O[SC_:/]Z;>_\`>=_G'^]6#Z?>/E_L4"*_WOO26TC;=<SZ-CA\R1^*
ML8^1?98&.U!!U$CA`&WM'RY1L-Q=>):6P#]*/#^2YR13&[&[<#7R"3^*G)\2
MF2365>3XE,28Y*222F,N\2@9!D-))$3W(_BCN<X2`PGS)`'_`'YRJ93JR&C(
M9`D["UVO\KLB$2.C6M=#_P!&X@1KM)B5'>_]]W^<?[T1U>.1++2/)[3_`-4Q
M"(@Q(/F)C\83F$VIQ<X0YSB/,G^]1KKK;:U[B]S6G5F]Q:=/W7E38UKC[G!@
M^!/Y$9K,,?2L)/D"/X)(H6+KZI\/*KR38VDN!J(#@Z1'THC_`#5<;,B23J%1
MZ;]A!O&)+G[AZQ=,S[MOTPUO[_T%>'(^(33OHSQNAQ5?@__9.$))300A````
M``!5`````0$````/`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S`&@`;P!P````
M$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H`&\`<``@`$,`4P`V`````0`X
M0DE-!`8```````<`"``!``$!`/_A$(9H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C`O`#P_>'!A8VME="!B96=I;CTB[[N_(B!I9#TB5S5-,$UP0V5H:4AZ
M<F53>DY48WIK8SED(C\^(#QX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C`Q,B\P,B\P-BTQ-#HU-CHR-R`@("`@("`@(CX@/')D9CI21$8@
M>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S`R+S(R+7)D9BUS
M>6YT87@M;G,C(CX@/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(@>&UL
M;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O(B!X;6QN<SID
M8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.GAM
M<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C`O;6TO(B!X;6QN<SIS
M=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87`O,2XP+W-4>7!E+U)E<V]U
M<F-E179E;G0C(B!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87`O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(@>&UL;G,Z<&AO=&]S:&]P/2)H
M='1P.B\O;G,N861O8F4N8V]M+W!H;W1O<VAO<"\Q+C`O(B!X;7`Z0W)E871O
M<E1O;VP](D%D;V)E(%!H;W1O<VAO<"!#4S8@*%=I;F1O=W,I(B!X;7`Z0W)E
M871E1&%T93TB,C`Q-2TP,RTP-E0Q,SHU-CHR-BLP.#HP,"(@>&UP.DUE=&%D
M871A1&%T93TB,C`Q-2TP,RTP-E0Q,SHU-CHS.2LP.#HP,"(@>&UP.DUO9&EF
M>41A=&4](C(P,34M,#,M,#94,3,Z-38Z,SDK,#@Z,#`B(&1C.F9O<FUA=#TB
M:6UA9V4O:G!E9R(@>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#HT0T4S,T8T
M0T,R0S-%-#$Q.#,T.$0S.3A&,48T-3!&,B(@>&UP34TZ1&]C=6UE;G1)1#TB
M>&UP+F1I9#HT044S,T8T0T,R0S-%-#$Q.#,T.$0S.3A&,48T-3!&,B(@>&UP
M34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)X;7`N9&ED.C1!13,S1C1#0S)#,T4T
M,3$X,S0X1#,Y.$8Q1C0U,$8R(B!P:&]T;W-H;W`Z0V]L;W)-;V1E/2(S(B!P
M:&]T;W-H;W`Z24-#4')O9FEL93TB<U)'0B!)14,V,3DV-BTR+C$B/B`\>&UP
M34TZ2&ES=&]R>3X@/')D9CI397$^(#QR9&8Z;&D@<W1%=G0Z86-T:6]N/2)C
M<F5A=&5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED.C1!13,S1C1#0S)#
M,T4T,3$X,S0X1#,Y.$8Q1C0U,$8R(B!S=$5V=#IW:&5N/2(R,#$U+3`S+3`V
M5#$S.C4V.C(V*S`X.C`P(B!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!0
M:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(O/B`\<F1F.FQI('-T179T.F%C=&EO
M;CTB<V%V960B('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z-$)%,S-&-$-#
M,D,S130Q,3@S-#A$,SDX1C%&-#4P1C(B('-T179T.G=H96X](C(P,34M,#,M
M,#94,3,Z-38Z,SDK,#@Z,#`B('-T179T.G-O9G1W87)E06=E;G0](D%D;V)E
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M:2!S=$5V=#IA8W1I;VX](G-A=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N
M:6ED.C1#13,S1C1#0S)#,T4T,3$X,S0X1#,Y.$8Q1C0U,$8R(B!S=$5V=#IW
M:&5N/2(R,#$U+3`S+3`V5#$S.C4V.C,Y*S`X.C`P(B!S=$5V=#IS;V9T=V%R
M94%G96YT/2)!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@<W1%=G0Z
M8VAA;F=E9#TB+R(O/B`\+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/'AM
M<$U-.D1E<FEV961&<F]M('-T4F5F.FEN<W1A;F-E240](GAM<"YI:60Z-$)%
M,S-&-$-#,D,S130Q,3@S-#A$,SDX1C%&-#4P1C(B('-T4F5F.F1O8W5M96YT
M240](GAM<"YD:60Z-$%%,S-&-$-#,D,S130Q,3@S-#A$,SDX1C%&-#4P1C(B
M('-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#TB>&UP+F1I9#HT044S,T8T0T,R
M0S-%-#$Q.#,T.$0S.3A&,48T-3!&,B(O/B`\+W)D9CI$97-C<FEP=&EO;CX@
M/"]R9&8Z4D1&/B`\+W@Z>&UP;65T83X@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`\/WAP86-K970@96YD/2)W(C\^_^(,6$E#0U]04D]&24Q%``$!```,2$QI
M;F\"$```;6YT<E)'0B!865H@!\X``@`)``8`,0``86-S<$U31E0`````245#
M('-21T(```````````````$``/;6``$`````TRU(4"`@````````````````
M```````````````````````````````````````````````18W!R=````5``
M```S9&5S8P```80```!L=W1P=````?`````48FMP=````@0````4<EA96@``
M`A@````49UA96@```BP````48EA96@```D`````49&UN9````E0```!P9&UD
M9````L0```"(=G5E9````TP```"&=FEE=P```]0````D;'5M:0```_@````4
M;65A<P``!`P````D=&5C:```!#`````,<E120P``!#P```@,9U120P``!#P`
M``@,8E120P``!#P```@,=&5X=`````!#;W!Y<FEG:'0@*&,I(#$Y.3@@2&5W
M;&5T="U086-K87)D($-O;7!A;GD``&1E<V,`````````$G-21T(@245#-C$Y
M-C8M,BXQ```````````````2<U)'0B!)14,V,3DV-BTR+C$`````````````
M`````````````````````````````````````````````````````%A96B``
M``````#S40`!`````1;,6%E:(`````````````````````!865H@````````
M;Z(``#CU```#D%A96B````````!BF0``MX4``!C:6%E:(````````"2@```/
MA```ML]D97-C`````````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````
M`````!9)14,@:'1T<#HO+W=W=RYI96,N8V@`````````````````````````
M````````````````````````````````````9&5S8P`````````N245#(#8Q
M.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@+2!S4D="````````
M```````N245#(#8Q.38V+3(N,2!$969A=6QT(%)'0B!C;VQO=7(@<W!A8V4@
M+2!S4D="`````````````````````````````&1E<V,`````````+%)E9F5R
M96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$`````````
M`````"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M
M,BXQ``````````````````````````````````!V:65W```````3I/X`%%\N
M`!#/%``#[<P`!!,+``-<G@````%865H@``````!,"58`4````%<?YVUE87,`
M`````````0````````````````````````*/`````G-I9R``````0U)4(&-U
M<G8````````$``````4`"@`/`!0`&0`>`",`*``M`#(`-P`[`$``10!*`$\`
M5`!9`%X`8P!H`&T`<@!W`'P`@0"&`(L`D`"5`)H`GP"D`*D`K@"R`+<`O`#!
M`,8`RP#0`-4`VP#@`.4`ZP#P`/8`^P$!`0<!#0$3`1D!'P$E`2L!,@$X`3X!
M10%,`5(!60%@`6<!;@%U`7P!@P&+`9(!F@&A`:D!L0&Y`<$!R0'1`=D!X0'I
M`?(!^@(#`@P"%`(=`B8"+P(X`D$"2P)4`ET"9P)Q`GH"A`*.`I@"H@*L`K8"
MP0++`M4"X`+K`O4#``,+`Q8#(0,M`S@#0P-/`UH#9@-R`WX#B@.6`Z(#K@.Z
M`\<#TP/@`^P#^00&!!,$(`0M!#L$2`15!&,$<01^!(P$F@2H!+8$Q`33!.$$
M\`3^!0T%'`4K!3H%2058!6<%=P6&!98%I@6U!<4%U07E!?8&!@86!B<&-P9(
M!ED&:@9[!HP&G0:O!L`&T0;C!O4'!P<9!RL'/0=/!V$'=`>&!YD'K`>_!]('
MY0?X"`L('P@R"$8(6@AN"(((E@BJ"+X(T@CG"/L)$`DE"3H)3PED"7D)CPFD
M";H)SPGE"?L*$0HG"CT*5`IJ"H$*F`JN"L4*W`KS"PL+(@LY"U$+:0N`"Y@+
ML`O("^$+^0P2#"H,0PQ<#'4,C@RG#,`,V0SS#0T-)@U`#5H-=`V.#:D-PPW>
M#?@.$PXN#DD.9`Y_#IL.M@[2#NX/"0\E#T$/7@]Z#Y8/LP_/#^P0"1`F$$,0
M81!^$)L0N1#7$/41$Q$Q$4\1;1&,$:H1R1'H$@<2)A)%$F02A!*C$L,2XQ,#
M$R,30Q-C$X,3I!/%$^44!A0G%$D4:A2+%*T4SA3P%1(5-!56%7@5FQ6]%>`6
M`Q8F%DD6;!:/%K(6UA;Z%QT701=E%XD7KA?2%_<8&QA`&&48BABO&-48^AD@
M&449:QF1&;<9W1H$&BH:41IW&IX:Q1KL&Q0;.QMC&XH;LAO:'`(<*AQ2''L<
MHQS,'/4='AU''7`=F1W#'>P>%AY`'FH>E!Z^'ND?$Q\^'VD?E!^_'^H@%2!!
M(&P@F"#$(/`A'"%((74AH2'.(?LB)R)5(H(BKR+=(PHC."-F(Y0CPB/P)!\D
M321\)*LDVB4))3@E:"67)<<E]R8G)E<FAR:W)N@G&"=))WHGJR?<*`TH/RAQ
M**(HU"D&*3@I:RF=*=`J`BHU*F@JFRK/*P(K-BMI*YTKT2P%+#DL;BRB+-<M
M#"U!+78MJRWA+A8N3"Z"+K<N[B\D+UHOD2_'+_XP-3!L,*0PVS$2,4HQ@C&Z
M,?(R*C)C,ILRU#,-,T8S?S.X,_$T*S1E-)XTV#43-4TUAS7"-?TV-S9R-JXV
MZ3<D-V`WG#?7.!0X4#B,.,@Y!3E".7\YO#GY.C8Z=#JR.N\[+3MK.ZH[Z#PG
M/&4\I#SC/2(]83VA/>`^(#Y@/J`^X#\A/V$_HC_B0"-`9$"F0.=!*4%J0:Q!
M[D(P0G)"M4+W0SI#?4/`1`-$1T2*1,Y%$D5519I%WD8B1F=&JT;P1S5'>T?`
M2`5(2TB12-=)'4EC2:E)\$HW2GU*Q$L,2U-+FDOB3"I,<DRZ30)-2DV33=Q.
M)4YN3K=/`$])3Y-/W5`G4'%0NU$&45!1FU'F4C%2?%+'4Q-37U.J4_940E2/
M5-M5*%5U5<)6#U9<5JE6]U=$5Y)7X%@O6'U8RUD:66E9N%H'6E9:IEKU6T5;
ME5OE7#5<AES672==>%W)7AI>;%Z]7P]?85^S8`5@5V"J8/QA3V&B8?5B26*<
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MEHO\C&.,RHTQC9B-_XYFCLZ/-H^>D`:0;I#6D3^1J)(1DGJ2XY--D[:4()2*
ME/257Y7)EC26GY<*EW67X)A,F+B9))F0F?R::)K5FT*;KYP<G(F<]YUDG=*>
M0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4XI:FF&J:+IOVG;J?@
MJ%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:OB[``L'6PZK%@L=:R
M2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"NCNZM;LNNZ>\(;R;
MO16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$SL5+Q<C&1L;#QT''
MO\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^XT#G0NM$\T;[2/]+!
MTT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;@-P%W(K=$-V6WAS>
MHM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?YZGH,NB\Z4;IT.I;
MZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGSI_0T],+U4/7>]FWV
M^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?___^X`#D%D;V)E`&1`
M`````?_;`(0``0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0("`@("`@("`@("`P,#`P,#`P,#`P$!`0$!`0$!`0$!`@(!`@(#
M`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#_\``$0@`/0++`P$1``(1`0,1`?_=``0`6O_$`-D``0`"`@,!`0$`````
M```````%!@0'`0(#"`H)`0$``@,!`0$`````````````!`4"`P8!!P@0``$#
M`P`%`PL."P4##0````$``@,1!`4A$A,&!S%!46%Q@9$BDM,45!4(H;$R0D-S
MDY345=465A=28G*"(S.S-,0UAL&R)'2THE,VT>&#HT1D)95VUC=7&!$``@$#
M``0)"`8(!`4%``````$"$0,$(3$2!4%189&AT1,4!G&!L<$B,F(50G+2,U-4
MX5*R(T-5%@?QDB0U\(*B8]/#1'0E-O_:``P#`0`"$0,1`#\`_=CF,QD[?)WD
M$%Y)'%'(P,8&0D-!AC<0"Z,N-7$G24!&^?LQY?+WD'@D`\_9CR^7O(/!(!Y^
MS'E\O>0>"0#S]F/+Y>\@\$@'G[,>7R]Y!X)`//V8\OE[R#P2`>?LQY?+WD'@
MD`\_9CR^7O(/!(!Y^S'E\O>0>"0#S]F/+Y>\@\$@'G[,>7R]Y!X)`//V8\OE
M[R#P2`>?LQY?+WD'@D`\_9CR^7O(/!(#GS[F@-8WTH:-.LYD#6TZKG1!M$'!
M7@-5Y/BX<2^5M[OE#&YCY`88?$[J8:KR-416]M*ZNCGHML;-V?NVV0KV\<''
MJKN5#:XDZOF52B9#TD+N#6;C9LQDGBH:^>*PL+>O,3K6TLQ%>H%(C@W'[\TE
MSE5>\28L:JQ8G-\M(KULHN1](CB?>:S+3*VV*B.@;"QM+FX`]_N;=S0ZGXJD
M1PK,=;;94WO$.\+NBW&%M<BJ^=]1`_?;Q9^W&2^(X+Z)6WNUC\)=/60_F^\_
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MO--/O;=.-1ZBV8_TDM_X=5N5?;Y!@T&2TCM[">G.=7Q>6%Q[`6B6#!Z83:Z2
MQL^)<J-%D8\)KC58OUHO./\`2&9>!HNLQE\5(:`BZLK.>$'G_3VUN_1UVJ//
M#O1]VDER?I+:SXAW?<HKFW;ERJJYT7FPXDW^4:'8[>R"\!Y!!)CW/[,1@;(#
MV%HE;G#WH-%K9R<;(5;&1"7D:KS:R3.]V]#>7+W(Z\-H/X98$AIK6<?7#>;Y
MXN/@K/Y,AX/KAO-\\7'P5G\F0#ZX;S?/%Q\%9_)D`^N&\WSQ<?!6?R9`/KAO
M-\\7'P5G\F0#ZX;S?/%Q\%9_)D`^N&\WSQ<?!6?R9`26+WJWBGN2R;*SR,V3
MW:IBM0*@MH>YMP>=`6'S]F/+Y>\@\$@'G[,>7R]Y!X)`//V8\OE[R#P2`>?L
MQY?+WD'@D`\_9CR^7O(/!(!Y^S'E\O>0>"0#S]F/+Y>\@\$@'G[,>7R]Y!X)
M`//V8\OE[R#P2`>?LQY?+WD'@D`\_9CR^7O(/!(!Y^S'E\O>0>"0'5^\.78U
MSW7\NJT5/Z.`Z/@D!&/WPS7N5W(.J]D!/>B&GJH#&=O7O"XU\YRMZC8;4#U8
M"@.OUIWA^=9_@K3Y.@'UIWA^=9_@K3Y.@'UIWA^=9_@K3Y.@'UIWA^=9_@K3
MY.@'UIWA^=9_@K3Y.@-/<4>)6_F$N\-'B=YKVQ9<6EW).V*VQCQ*^.>)K'$S
MV$Q!:UQ&BBG8=JW<C<<X)NJ.9\0YN7B3Q%C7W!2BZT2==*XTS5HXS\4B:#?7
M)$]`L\(3VAB25,[O8_"73UE!\WWG6G?I5\D?LGM+Q#XRY>$10[Z[SV(-2+JR
MM]W;205YR^\P5Q&YHZ-5>*&+!U=N#Y'7U,]GD;[RH;,,V_#XH[$?VH-=!5KI
M_I*RR"3'>DCO#8PDU=:9'=C<V_F:/P67=ON[`RO5<TK>KV[EHGNR+?&I27K*
MNYNOQE)[5CQM>A#]6=JS)_YE;7H(:#B?QLP5W-:Y/BYO=E;VTE,4XNK/<^.U
M,C1[6&SW:BUHW`@CNP5GV.)=BI1Q81B^+:KTR(D,[?\`A79VLC?V3=O1='56
MDJ^2-M:/.2OWZ<7OMYE/B.!^B%CW3&_!73UDGY_OG^83YH?9'WY\7OMYE/B.
M!^B%[W3&_!73UCY_OG^83YH?9'WY\7OMYE/B.!^B$[IC?@KIZQ\_WS_,)\T/
MLC[\^+WV\RGQ'`_1"=TQOP5T]8^?[Y_F$^:'V1]^?%[[>93XC@?HA.Z8WX*Z
M>L?/]\_S"?-#[(^_/B]]O,I\1P/T0G=,;\%=/6/G^^?YA/FA]D??GQ>^WF4^
M(X'Z(3NF-^"NGK'S_?/\PGS0^R/OSXO?;S*?$<#]$)W3&_!73UCY_OG^83YH
M?9,>YXV<7KF(Q?>'GK:ONMG:[NQ3-ZSI<%.RGYJ+%QDZ]A%^6O687-][YN1<
M?F=V/+%03Z8/T%'R7$GTB'ZS\+Q]WGMS[6WRF[^YEU'7H-Q;[N12@=6A4B%K
M`7WF[XM<CDO64V1E^*W5X?BV_%\4[=EKG5M/H*#DN,7IDX\.=%Q0RF5C;7N\
M;8[FOD<!S^+S[MPRBO0*E2H8^Y9:\91?+M=91Y&]O[DXZ;COJ=V*_45FO,[:
M90KWTJO2EQKS'D>)V]-B\:-6[W>W5@[3G[LAI[!4F.[-US588\&N1R^T4=[Q
MMXYQWLY&^<B$OBMVE_Z1ACTN_24.D<7LX1TC$;GGUMW%E\IW=^4CSRZS5_7W
MC%ZO$%W_`"6O_&<__KKTE?\`[=SO_D^Z'_MM/E.[?RD>>76>_P!>^,OY_=_R
M6O\`QFP^'O&CTQ>)]W?6NZO%+(OCQ;;=^2OLC:;FV5E9BZ+Q;M<X[LR3322;
M-Q#6,)HTUHHN5C;FPXQ=_&57J2VFW37](OMP[X_N/XDNWK6[-]R:MTVY35F,
M8[5:?PVVW1Z$N`^G=WL9Z2QU)=\/2:SS10&2QW6W5W/J>EOG#*;NFG7;&%37
M<K=VE8^ZH^64I>A,^DX'A_QDZ2WMX[N\L;-FU^W.WZC=V'WEWRP]OL';];TY
MMY`U[K/.P-Q,2.>-MA@L?%%7G%'*NN.-QU[*$>2-?6V=EB6+N)#8>?D7GQW7
M!OFC"*18;/?K>^2Z@8_/73F.>`YI@Q]"*'0:68*TSC%1;2)UN<Y7()RT5++]
M;MY?G>?X&S^3+42S(CWUWB9027QE'/6&W8[MMAIZB`SH]]LBZ@DN[F,](9;O
M;R]2(.':*`E1O!EW`$9"4@@$'4@T@Z1[D@.?/V8\OE[R#P2`>?LQY?+WD'@D
M!8_.5_J5\:?7ZJ^/5U8OWSQC4\8_5^SU=%/8]1`?_]#]S^>_G%_[ZS]A$@(A
M`$`0!`$`0!`$`0!`$!%9?.8?`PMGR^0M[%DE=DR1VM/-3EV-NP.FD[`HLX6Y
MW'2$6R/DY>-B14\F\H)ZJZWY%K9KK(<7\';ZS<;C\ADGC0'RZEC;D]-7[29S
M?S05*A@W'[\DNDI;WB3$AHL69S?+2*Z:OH*-D.+>]-UK-L(\=B(SR.A@-W<@
M>_7)+0>LU2(X5E>\W)\Q57O$6?<T68PMQY%5\[ZBBW^<S>5<79++Y&\J2=26
MZD$(KS"&,LB`["D1MVX>[!+S%3>RLK(=;^1.7E;IS+0:MD#6R2ZH`!D?[&@!
M[H]'*LR/1<1U0!`$`0!`$`0!`$`0!`$`0`:'![26O'(]I+7BG)1[2'"G70<-
M5K++C=\]ZL3JBRSM]LVT_073Q>P$?@ZER)"!UB%JG8LSTRMJI.L;SWACT[++
MGL\3]I=-2]X_C%EHM5N5Q-C>MT!TMF]]E-U3J.VL!/8"C2P8/W)M>726UGQ+
MDQHLC'A-<:]E^M%YQW%3=6\U6W3[S%/-`?&X-I"TG_O%L9&@=4@*/+#O1U)2
M7(6MGQ!N^[17'*V_B55SHV%;W%O>0175I<0W5M,W6BN+>1LL,@Y]5[214<XY
M1SJ,TXMQDJ,NH3A=A&Y;FI6WJ:=4SV7AD$`0!`2V&_?#[R_^\Q`6I`$`0!`$
M`0!`$`0!`$`0'A<_N\OY!0%>0!`$`0!`=2]K>4@?\R`\C..8$]?0@-8[^XVR
MR=WBI;R(R^+VUTV-@D<QE'S1..N&^RTM4S&G*,9[+UM%#OG'M7YXLKL:T32Y
MT56"SM+44MK6W@ISQQ-#N_H7>JMS;EK;9`A9LV_N[45YC(7AM"&+U,T#O3_Q
M+F_\Z?V<:L\?[FWY#A]Y_P"X9?UR"6X@!`$`0!`$`0!`$`0!`=961SL,4\<4
M\1!!BGC9/&0>4&.5KV>HFIU6AB24TXSBI1XFJKI*9E.'.Y66+GSX*"UF=_VC
M&/DQ\@)]L6PNV+CUVK?#*R+>JZVN725&3N#<^55SPHQGQPK%]&CH-?9+@?:.
MUG8;/W$/+JP92V;<,'4\8MS')0=):5*AO&7\2TGY-'0461X-M.KP\Z2Y)JJY
MU1]!]%>BQN5FMTY-_&Y(6LT=V<#XM-9S;5LFQ&1$A=&]K)(B-<:"%4[ZR+=]
M8NQ5-5K7S'?_`-M-SYF[);Z61L.,G:HXNM:;5=&AK6?6Q!;H<"T]#A3UU1GU
M4X0&78_OEO[Y_85C/W6;+7WD/*6Y:":$`0%TA_51>]L_NA`>B`("V>Y_T7_%
M(#__T?W/Y[^<7_OK/V$2`B$`0!`$`0!`$`0!`=FL>_0QCGD<H:TN/J`H>I-Z
ME4ZD$&A!!'*#H(ZX0\Y.$^3.($LLN^^\6UD?)L+MMO#KN+A#!'#'J0Q`FC(V
M]`T5TJYQJ=WM:-:J?/-\-O>F8VZTE1<B26A%16\K0@'6T'I0$+=8>.5SI(7[
M)[B2YI%8R3I)`!#FU/70$5+BKV.I$0D`K^J<''EI[$T=I0&`^-\>B1CHST/!
M;Z_70'5`$`0!`$`0!`$`0!`$`0!`$`0&[.#$TVVW@M-J_P`5;!97+;?6)B9<
M/FEC?,QG(Q[V-`)'+SJOSTOW3I[6DZGPQ*6WFV]I]GLQ=."M7I-ZJO.L"`]8
MK>>8TBAEDZK6&G7UC1M$!(Q8:[?0R;.$$<A=KN'4+6:`>R@)RRL(K,$@E\KA
M1TA%-'+1K1[%M>N4!G(`@"`(`@"`(`@"`(`@"`\+G]WE_(*`KR`(`@"`QYG$
M4`-`0:]5`8Z`("D;W?KK'WB?]HQ2L?W9>5%1O3WK'G]13U(*T(`O#QZF:!WI
M_P")<W_G3^SC5GC_`'-OR'#[S_W#+^N02W$`(`@"`(`@"`(`@"`(`@"`("Z[
MF;YR[H2WI%@R_M[\0"9FV,$T;K<OU'0OU7L-1(:AP[*C9&/VZC[5&BXW1O>6
MZIW7V"G"=*JM'HXN<W!8<5=T[X".^\>Q3G4!\;M]O`T\E1/:F35ITD!0)X=^
M/NI2\GZ3K;/B?=5Y4O*=J7*JKG1*8+>W=/>=A?NYO1@,Y1SFNBQ^5M9;ECFN
M+2R2T?(RZ:\$4IJ+7<L7[.B[9G'RITY]1,P=Z[JWDJ[OWG8O_5FF_/%M-<Q;
M;-CF7MNU[7,=M.1P+3R'F("CS:V7I+2VFKL$U1U+9ST&D]`TGM#2M),,J.RN
MY::L#P#3NGC4;0\_=4*`SX\/(:&65K1SA@+CUJG5'KH">:T-:UHY&@-%>@"@
M0'*`("V>Y_T7_%(#_]+]S^>_G%_[ZS]A$@(A`$`0!`$`0$/G-XL!NQ8.RF\F
M:QN!QS7B/QS*7+;:)\I!<V&$'6DGG<UI(8QKG4TTHL[=NY=EL6H.4N)$;+S<
M/=]EY&=E6[-BM-J3HJ\2X6^1&@]X?2OX38?7CP[\]O?<MJ&C$XTV-@YPY*Y#
M*.@;J'I#"I]O=.7/W]F"Y75\R..S?[B>'<:L<9WLF:_4CLQ_S3IT(T;O!Z86
M]U[KQ[L[JX3`1&NI<9.:?.7H')4QCQ2R:ZG4>%/M[GL1^]NRD^30O6SD\W^Y
M>\KM8X&[[5F/')NY+U1])I'.<:.*V\,NTR&_6=B:':S+;%7`P]I&>;4@QS8!
MHZI*FPPL2VJ0QX^?2^DY3+\4>(<Z5;^][R7%!["7FC0G-WO2'XO;N[.-F]<N
M9MHP`VUWCM8,NW5'M1<2".\;UQ)587-WX=S2[-'\.C]!+PO&OB3"I%;Q=VVN
M"XE/I?M=)4\OZ65Q+O;G'[T[F12&6^K+=;NY`QN'Z*,%PL<B'`DTY!*I-O=*
M5FWV5[@X5ZT1LC^X,YY^3+/W:JRE5NW+D_5EUE^P7'_A5G=2,[P28&Z>!_AM
MXK*?'@.YVB\8V>S-#SZP"T3W?EPJU;VER:>C66^+XMW!E47?':F^"Y%QZ=*-
MPQ30W$4<]O+%/!-&R6&>&1LL,T4C0Z.6*5A<R2-[34$$@A0VFFTU1G11E&<5
M*$DX-536E-<C/1>'H0!`=7-:\%KVAX(H0X!PIV:H#!EQEG+[D&'IC)9R]05;
MZB`CY,&-)AN".6C9&5`Z!K-.GM("/EQ5[$*[(2@<IB<'4%.4@T<.1`8+V/C-
M'L<P]#FEI]4!`=4`0!`$`0!`$`0!`$![1V\\OZJ&1_26M-!V30(#>W!3#W;[
M[>'7V<+?$<?77=K/H;F8^Q96G;4#/7LVGP59T_AC[[-^I'TL^BH\'"W];-)(
M><-`C;_:[UE7'7$C'8VD6EEO'7I<W7/-IJ_6(.A`97-0:!T#0.UR(`@"`(`@
M"`(`@"`(`@"`(`@"`\Y6;2-[*TUFD5I6G8T("'?8W#.1HD&GV#A717VIH>9`
M8KF/8:/:YI'2"/70'5`$!C3\K>L?70'@@"`I&]WZZQ]XG_:,4K']V7E14;T]
MZQY_44];RM,>XN[2T;KW=U;VS>F>9D?::XZQ[`7J3E[J;,+EVU:5;MV,5RM(
MK-YOQN_:U$4\]_(![&SA=J5YAMIMFRAIRZ5NCCW9?1HN4K;V^L"W51F[C^%:
M.=T-/Y.]=D\C>Y%T8A-Y.Z;8AVL(P0&M;K'V1#6BIZ5/A#8A&%:T1R>3>>3D
M7K[C3;E6G$82S-`0!`$`0!`$`0!`$`0!`$`0!`<CE7AZM:/@BX8V._NIHM:&
M9MY=%LT#W03`^,2:1+$62`]E=+'W(IZJ'Q"24;UR<=$]MZ5H>M\*TGTSZ-W$
M/?R7BYPYW6N-[\]>;N97>*&SR&(O[Z2^M;BU-K=/V-;K:S1,UF`]PYO(JC>N
M)B]RR;RQXJZHU32IP\A]!\">(-^KQ)N3=TM[7Y8-R\HRA*3DFJ/1[56O,S^R
M<<,40&SC8SJM:T'KUI6NA<0?IY:CT0!`$`0!`6SW/^B_XI`?_]/]S^>_G%_[
MZS]A$@(A`$`0!`$`0'Q_Z9+6NW/W'U@'4WKR!%16A\RRZ157.Y?O<CZB])\S
M_N>D]V[HJO\`W$OV&?S]5\?'`@"`Y8UTK@R)KY7G0&1-=(XGJ-8'.*:M+U!)
MR=(IM\FGT&L,MPYWVS>\N7DLL!<QV\EY5MWD'QX^V+=FSNP9W"5S1U&%3(9>
M/;M04KGM):EI*^]N+>V7E7I6L.2A77*D5TZ>@LV-X!9"9H=G]X;*UC+>[ML5
M:R7LI!&EIGN3%"".D-*U3WC%?=6FWQMT]!8V/!EZ5'EYT8KB@MI\[HC^C6XF
MZ>)Q.YNZV/B%Q<QV6!Q]K'+<24D>R**C7/;%JL#CSTT+G+^1<G>NRT)N3/M6
MZ=U8F/NW`LI2DHVHI-OB7(6PX3&D4\7U>JV20'^\5J[6YQE@\#$:IV-/(V8$
MV[<#JFWN98CIHV1K96]L:KEDK[X8HCSW9;=7;NM/ETKK(J;`9&+2QL5R.F)X
M:ZE?P)-4U[*S5Z#UZ")/=V3"NRE)<C]3(N:">W-)X98ORV.:.W2A6Q-/4R).
MW.VZ3@T^5'B#7D7I@<H`@.CF,>*/:UXZ'`.'^U5`84F,LI*G8ZA.FL9+--.C
M2WU$!'RX/E,-QUFRMK_M-I7LH".EQ=[%[D)!2M8G!_)R]SH=5`83F/8:/8YA
M',YI:?5"`ZH`@/6.":7]7%(_JM:2.WR("0CP]X_2_9Q#\9VL>;VK*^N@,^/!
MPMIM9I)".4-I&#V>Z*`D8K&TATL@96E-9PUW=M^L@,H"@H-`Z!H"`W-P8_F&
M\?\`D+#_`%,R@Y_N6OK/T'3^&/OLWZD?2S?BK3K@@"`(`@"`(`@"`(`@"`(`
M@"`(`@"`(#@@'00".KI0&.^TMW\L8!Z6]SZVA`8S\<TU,<A!Y@X5'9(H4!%7
M=I-&YHHUPU206GJTY#0H#!V<E::CJ]8H#T%O*>8#KG_DJ4!I3B_G[S=VXP<-
MI#;327EI?2&:?:$1"*XA8`V)I`>7:U:DCD5C@V5=5S:>A-'(^)]X7<*>'"U;
MBW*,G5UT4:6HT!>;TY^]J)<C+$P\L=J&VS".@F,!Y'YRLXV+<=4:^4XN[O/.
MO>]D-+B6CT:2!>3(XOD<Z1YY7R.<]QZ[GDE;EHT+406W)UDVWRZ3A#P(`@"`
M(`@"`(`@"`(`@"`(`@"`(#D<J\/5K/@JZ_>[O_-W7[>1=+'W8^0^(S^\N_7E
MZ6;G]&S_`.>^%/\`ZK@_T=ZH&]O]NR_J^LZCP+_^Q\.__(7H9_<=<`?K5:D$
M/0@"`(`@+9[G_1?\4@/_U/W/Y[^<7_OK/V$2`B$`0!`$`0!`:*X_<+\YQ3W9
MPN/W?OL99W^#R\^4V.5?-#;WT4]B^S=#'=1,E\6F87!P+FEKN30I^[\N&)<N
M2N1;C*--'`<CXQ\/Y?B'!Q;.%=A&_9N.5)U2DG&E*JM'PZ50^$LGP$XL8FX?
M#=;IS2QLJ3?6%Y:7]AJ@T+MO;R.D`YZ%@/45Y'>&'-55Y5XGH9\EO^#?$N/-
MQGNQN/ZT9*4>=:>@QK3A3?!^KF,K#8.![JVM[>22X'XI?<"%@/YI63RH_0A7
MSBSX8O-TRLJ,.1)M]-$7"QX<[K6>JZ:VN<G(*'7OKAVH3U((-E'3MK3+)NMZ
M'3R%O8\/;MLI.<)7)_$]',J(M]K8V%@P,L[.TLV#FMX(HN3I>UH>>R2M3<I>
M\VRWM6+%A)6;,(+D213[V"YO<M>1VEO<7<AGH&V\,LQ/<M_`:X+9%J,%5I$"
MY"Y=OS5N$I.O`FR=LN'^]-]2MBRP8[W3(3,AH.G9,VLQ/4H%A+(M+Z5?(3+>
MY\^Y2MI07Q/U+2?0&)LW8[%X_'OD;*^RLX+9\C`6LD=$P-<YH=I#2>2JKY/:
ME*2X6=?8MNS8LV6ZN,4J^0D%X;0@"`$`BA`(/,0".T:A>#6J/48$V+Q\]3):
MQAQ]O%6)W;90'M+-7)K5(CW,3&N)[5I5Y-'H(F;=J$U-M=2Q\M&3-;*T='=M
MU7K8K[X8HASW7!U[.\UY=)%38'(Q5+613M'(8I`''I[B34*V*[!\+1%GN_)A
MJ2DN1^HBY89H"1-#+$1^&QS1S\Y%-%%L33U,ASA.VVIP:?*CR!!Y#7K(8G*`
M(#JYC'BCV->.AS0X=H@A`8KL?9.K6VCT\M-8=/0ZG.@.S+*TC-66\0/3JZW/
M7VQ=32AZ9(``H!0#D`T`(>'*`(`@"`W+P8_F&\?^0L/]3,H.?[EKZS]!T_AC
M[[-^I'TLWXJTZX(`@"`(`@"`(`@"`(`@"`(`@"`(`@"`(`@"`C;[V<?Y)]=`
M8*`(#6?$CAZ=^+:RGL[]ECE\6V=EJ+EKGV-W!<.8^2WG+`9()-=@+)`"!I!%
M%+Q<KN[DI1K!\6M%!OW<OS:W:G:NJ&5;K2ONM/6GPI\3/FG*\-M]\/K.N=W[
MNXA96MQC2S(PT'/_`(<NE`T<[`K:&7CSU74GRZ/2<)D[AWMBU=S"E**X8^TN
MC3T%'D#H9#%.Q\$K31T4['PR`CE!9*&NJ%(5'J=2IDG![,TU+B>A](7IX$`0
M!`$`0!`$`0!`$`0!`$!P7-'*0.N?6052X21L\3E,@1XCCKRY!Y'QP/$?7VKP
MV.G96$KEN'O32)%K%R;].QQYR\BT<^HF9-R=Z(V:YQ4CP!4MCFMY)`/R&RU)
MZRU+*L/1VA,EN;>48[7=F_(TWS5*]<6MU9R"*[M;FVD)H&3P2QN)Y*`.:*]A
M;E.,E6,DT5\[=RS)1NVY1?*FCY/W>X,<6-][NX=NSP^WFOK:2[N:7\^/?C,:
M&F>2CS?9,VEN64TU!.A7=S.P\>*5[)@G356KYE4^68/A;Q'O:Y-X&YK\X.3]
MIQV(ZW]*=$?<WH\>B)G=R-ZL3Q#XCY.QAR>`E=>;O[JX.X-[L\B^&2%E_G,J
M&LMW,M62N++:`.#GD%[Z"BY_>>^K=^S/&Q8-PEKD]&CB2Y>-GUSP3_;3+W5O
M'&WWOW(@K]EMV[-M[5)4IM7)ZM%72,>'6S[\7.'V0(`@"`(`@+9[G_1?\4@/
M_]7]S^>_G%_[ZS]A$@(A`$`0'BZXA96KP2.9O='U-"`QWWS1[!A/5<:>II/*
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M01:S-`0!`$`0!`$`0!`"`11P#ASAP#FGK@@A!KT/2B/GQ..N/UEJQKOPX:PN
M[;*`]I9*Y..J1'N8F-=KM6DF^+1Z"*FW;B.FWN9&?B2M$@[]NJY;%??#$ASW
M7!_=W6O+I(J;!9&*I9&R<#GB>-8_F/U3IZ-*V*[!ZW0BSW?DP]V*DN1]9%21
M2PNU)HI(G?@R,<T]BHH5L33U.I#E&4'LSBXOE5#HAB$`0!`$`((Y01UPA[0(
M>&Y>#'\PWC_R%A_J9E!S_<M?6?H.G\,??9OU(^EF_%6G7!`$`0!`$`0!`$`0
M!`$`0!`$`0!`$`0!`$!S(!#&Z:=S+>%HJZ:X>R")HZ3)*YC*=E%I=%I8?LQ<
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MX;.PTOK#%9J!PT.GM[:\T'G;,`96]AP6$93MOV9.+YB3=Q\;,A2]8MW8<J4N
MG7TFNLKP7W$R!>^TM+[!S.J:XR\>8`[I\4NMM$`.@44N&?DQHG)27*BCR/"N
MY[U7;MSLR^!Z.9U1KC*<`\I%K.PN>LKYNDMAR4$EE,>@&:';0$]6C0I4-Y1?
MWEIKR:2BR/!V1&KQ<R$UQ26R^=51K?+<.=^,,'ON]W+Z:!E2ZYQP9D8`![;6
MM7/>&]=H4NWE8]RE+J3XGH*/)W'O;$J[F#-P7#'VET=127G9O,4H=#*#0Q3,
M=#(".4&.0->.TI"TZM**EZ&U)4EQ/0^DY0!`$`0!`$!P2`*D@`<I.@(-6EF?
M98O)Y%P;88Z]NJ\CHK>39_".#6>JL)7+<%6<TC?9QLF_3L;$Y>1.G/J+=9<.
MMX+FCKKQ3'L-*B:;;2@<_P"B@#@#U"X*/+-LQ]VK+2UN#.G1W'"VN5U?,BV6
M?#/%14.1O[R\=_NX-2TB<><=SKS$?G*-+.N/W(I(L[/A[&C1WK\YOB7LKULO
M.+W-Q=J`<;N_#44I<30[>2M>4S7)=IYU&GD79>_=9<XVZ<>U1X^`J\;5>EEQ
MBP%X\`2R0P,YF`F2G4#&:K&TZZC[<>`M88-UI;<E%<_Z"2AW>LF4,SYISS@N
MV;#V&::=E8]I+@)$<&RO>;;YB6BL[2`-$5K;C5(+2Z)DC@1R$.E#R".D+%R;
MULDQM6HJD;<:>2OI)UN1O10.N))6MT-;,=HUHI0!H=[$#J+RAM;;I5U,IF5=
M2DD0.@:6$BO5(=5#PS&9"U?0%YC)_P!X"`.NX5:.V@,MKFOTL<UX_%<#Z@TH
M#L@"`(`@+9[G_1?\4@/_UOW/Y[^<7_OK/V$2`B$`0&#>[35;2NS]M3DUM--;
MGY.P@(U`$`0!`$`0!`$!JO>,1>>+PQ.D+S(-NV1K6M;+J,KLGM>XO81TM:05
M-M5[.-=7`4&9L]XN;#=:Z?T$(MI%"`(`@"`(`@"`(`@"`(`@,2_\4\5D\>U/
M%]4^S]EK4.KL?;;36Y*<Z]CM;7L:S7?[+LI=XIV?+ZN7R&MQR<_9Y:<U>K3E
M4TY=:M)R@"`P,@_*,A_\)M<=<W))%,G?75C;L%-#M:TQV1ED)/**,H.=91V*
M^VVER*OK1JNN^H_N(0E/XI.*Z(R-1;RGCFZ.0XIN[D45#1F[TC9[T-Z&R9N.
MVE+J?@L"FVOE]5M[=>75T%!F?U*XOL5:4?\`MZ9<\J/H->X'[_O''[`Y\#:?
MI_K`+(X_6KI_?G!NK[WS<BE7/EVRZ[.K@U]!4XO]5=I[/;:]/:4V>GU&]\-+
MQ)8V,9ZRW+N`:;1]EE,M9W(&BIV<>'O[-S@/P7`55=-8O\.5SSI=:9U&/+?"
M2[U;QFN24D_V&ND^J>#0L`,X6/NG91T5F;ICXHV6<5IM)-BVVD;-)+/*9:ZY
M>V.@I0%4^?M?N]'L:?+YSO?#*M5RJ.7>**NCV5&KI1U;;KKJER&[U7G5!`$`
M0!`$`0!`$`0!`$`0!`$`0!`$!V;J^V+@/Q6AWKN:AZJ<.HB,I+G6,(P=AAKJ
M2G<OS&7O[&,'I,=AA,B\C\X+."MU_>2DER)/TM$;(EEJ+[I9M2E\<Y17-&$O
M2:6WF'I!2%WB+L':V)UM<[F,M[_*LCH=$(S[\;<2O/4+%.M?+5[VTY?%H7_3
M4Y;/_K*3_=NS&SP]A24_-VC@V^8T7DVXMMY3B9+Q1GFUNZ=O/;W5KC*]1F.N
MKR/9U_&I13X]KLKN:L)?"ZOI2.9N+`5S_P"_GO&4Z_Q4XP_Z)2])LO=K[MO-
M<_F/S+XEM6;7Q,R[;;;,TVNC;[75Z=-%!N][VUVVUM\O$=-N_P#I[NTNX=CV
M5=.S6M>7AJ>=V-W2X^*ORC/R8H98NP)YH90$CVG#0PNK`=>R=Q>9-=+1"NU0
MXAI+FU[ESFACB.ES`YX:>R5GY2(Z5=-1PO3PX-*'6I3GKR=FNA`95AX_MAYJ
M\>V]='F_;ZW9V/<TZZ\ELT]NE.4SM=KM?Z?;VOAKZC:&'^\6C-ILS#04&:V(
M=JZ.>.MV-'442?=O/R?\4.@QOG=---GXZ?XE]LWY8@#(6V,:>=]E>W;O^KN+
M!E._4>6Q]%OSK]);VWD?QH6_^63]<?62C=:OZ(R:WXH-:<^EI)6'E)"K5;-:
ME9WD^I_B[_K=]6]EJFOGCQ+;4H:ZE?\`$ZW6TK=:[>O[C;KR5*_.^5[+^9=A
M3X]FO6?.&\@X(%[QBW9V.6I[O=QCYK,'3[&/,206Y%?P7!6EGYA]+9I\6OH.
M'S_Z3;_T[O*7_:TQYIT7,S4V1CQ+'DXB\REQ'70W*XVSLY`*\ADLLM?,<:?B
MA3H.Y_$BEY&WZ4CF[\<9/_37;DE\<8Q_9G(C6ZU.Z`!_%<7#U6M69H.R`(`@
M+3N7YM^L5IYT\6\7V<^R\<U?%_&]0>+ZVO\`H];6KJZVBJC9.WV4^SK71JXN
M$L]T=AW^SWC9V*.FUJVN#7HKQ5/HZ,5:W6<60Z*&!C)&4_%#7Q1=I4SUZ=9W
MBU:_9Y/\4B2MQA@1MW7KM/*]C&1]D0OD?3LK%[?!0DV^YU6VYORZ%T-EFL?-
M%!XEXIK?F[6O_2]W7K+7+:^E4LK7=:?N=CU].DE-.CHYNCL<RQ)#KPG"'@0!
M`9"`(`@.S-?7&SUM>HIJ5UJZ*4U=*`MC*ZC=:M=5M:\M:"M>K5`=D`0!`6SW
(/^B_XI`?_]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g911894g68q31.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g911894g68q31.jpg
M_]C_X``02D9)1@`!`0$!+`$L``#_X@Q824-#7U!23T9)3$4``0$```Q(3&EN
M;P(0``!M;G1R4D="(%A96B`'S@`"``D`!@`Q``!A8W-P35-&5`````!)14,@
M<U)'0@``````````````````]M8``0````#3+4A0("``````````````````
M`````````````````````````````````````````````!%C<')T```!4```
M`#-D97-C```!A````&QW='!T```!\````!1B:W!T```"!````!1R6%E:```"
M&````!1G6%E:```"+````!1B6%E:```"0````!1D;6YD```"5````'!D;61D
M```"Q````(AV=65D```#3````(9V:65W```#U````"1L=6UI```#^````!1M
M96%S```$#````"1T96-H```$,`````QR5%)#```$/```"`QG5%)#```$/```
M"`QB5%)#```$/```"`QT97AT`````$-O<'ER:6=H="`H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0``9&5S8P`````````2<U)'0B!)14,V,3DV
M-BTR+C$``````````````!)S4D="($E%0S8Q.38V+3(N,0``````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````%A96B````````!O
MH@``./4```.06%E:(````````&*9``"WA0``&-I865H@````````)*````^$
M``"VSV1E<V,`````````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````
M````%DE%0R!H='1P.B\O=W=W+FEE8RYC:```````````````````````````
M``````````````````````````````````!D97-C`````````"Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M('-21T(`````````
M`````"Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92`M
M('-21T(`````````````````````````````9&5S8P`````````L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0``````````
M````+%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$``````````````````````````````````'9I97<``````!.D_@`47RX`
M$,\4``/MS``$$PL``UR>`````5A96B```````$P)5@!0````5Q_G;65A<P``
M```````!`````````````````````````H\````"<VEG(`````!#4E0@8W5R
M=@````````0`````!0`*``\`%``9`!X`(P`H`"T`,@`W`#L`0`!%`$H`3P!4
M`%D`7@!C`&@`;0!R`'<`?`"!`(8`BP"0`)4`F@"?`*0`J0"N`+(`MP"\`,$`
MQ@#+`-``U0#;`.``Y0#K`/``]@#[`0$!!P$-`1,!&0$?`24!*P$R`3@!/@%%
M`4P!4@%9`6`!9P%N`74!?`&#`8L!D@&:`:$!J0&Q`;D!P0')`=$!V0'A`>D!
M\@'Z`@,"#`(4`AT")@(O`C@"00)+`E0"70)G`G$">@*$`HX"F`*B`JP"M@+!
M`LL"U0+@`NL"]0,``PL#%@,A`RT#.`-#`T\#6@-F`W(#?@.*`Y8#H@.N`[H#
MQP/3`^`#[`/Y!`8$$P0@!"T$.P1(!%4$8P1Q!'X$C`2:!*@$M@3$!-,$X03P
M!/X%#04<!2L%.@5)!5@%9P5W!88%E@6F!;4%Q075!>4%]@8&!A8&)P8W!D@&
M609J!GL&C`:=!J\&P`;1!N,&]0<'!QD'*P<]!T\'80=T!X8'F0>L![\'T@?E
M!_@("P@?"#((1@A:"&X(@@B6"*H(O@C2".<(^PD0"24).@E/"60)>0F/":0)
MN@G/">4)^PH1"B<*/0I4"FH*@0J8"JX*Q0K<"O,+"PLB"SD+40MI"X`+F`NP
M"\@+X0OY#!(,*@Q##%P,=0R.#*<,P`S9#/,-#0TF#4`-6@UT#8X-J0W##=X-
M^`X3#BX.20YD#G\.FPZV#M(.[@\)#R4/00]>#WH/E@^S#\\/[!`)$"800Q!A
M$'X0FQ"Y$-<0]1$3$3$13Q%M$8P1JA')$>@2!Q(F$D429!*$$J,2PQ+C$P,3
M(Q-#$V,3@Q.D$\43Y10&%"<4211J%(L4K13.%/`5$A4T%585>!6;%;T5X!8#
M%B86219L%H\6LA;6%OH7'1=!%V47B1>N%](7]Q@;&$`891B*&*\8U1CZ&2`9
M11EK&9$9MQG=&@0:*AI1&G<:GAK%&NP;%!L[&V,;BANR&]H<`APJ'%(<>QRC
M',P<]1T>'4<=<!V9'<,=[!X6'D`>:AZ4'KX>Z1\3'SX?:1^4'[\?ZB`5($$@
M;""8(,0@\"$<(4@A=2&A(<XA^R(G(E4B@B*O(MTC"B,X(V8CE"/"(_`D'R1-
M)'PDJR3:)0DE."5H)9<EQR7W)B<F5R:')K<FZ"<8)TDG>B>K)]PH#2@_*'$H
MHBC4*08I."EK*9TIT"H"*C4J:"J;*L\K`BLV*VDKG2O1+`4L.2QN+*(LURT,
M+4$M=BVK+>$N%BY,+H(NMR[N+R0O6B^1+\<O_C`U,&PPI##;,1(Q2C&",;HQ
M\C(J,F,RFS+4,PTS1C-_,[@S\30K-&4TGC38-1,U336'-<(U_38W-G(VKC;I
M-R0W8#><-]<X%#A0.(PXR#D%.4(Y?SF\.?DZ-CIT.K(Z[SLM.VL[JCOH/"<\
M93RD/.,](CUA/:$]X#X@/F`^H#[@/R$_83^B/^)`(T!D0*9`YT$I06I!K$'N
M0C!"<D*U0O=#.D-]0\!$`T1'1(I$SD42155%FD7>1B)&9T:K1O!'-4=[1\!(
M!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-`DU*39--W$XE
M3FY.MT\`3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?4ZI3]E1"5(]4
MVU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:5EJF6O5;15N5
M6^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/8:)A]6))8IQB
M\&-#8Y=CZV1`9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H[&E#:9II\6I(
M:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&<.!Q.G&5<?!R
M2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YXS'DJ>8EYYWI&
M>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$>`J($*@6N!S8(P@I*"
M](-7@[J$'82`A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)_HIDBLJ+,(N6
MB_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+CDTV3MI0@E(J4
M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY`
MGJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:IHNF_:=NI^"H
M4JC$J3>IJ:H<JH^K`JMUJ^FL7*S0K42MN*XMKJ&O%J^+L`"P=;#JL6"QUK)+
MLL*S.+.NM"6TG+43M8JV`;9YMO"W:+?@N%FXT;E*N<*Z.[JUNRZ[I[PAO)N]
M%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%R,9&QL/'0<>_
MR#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="ZT3S1OM(_TL'3
M1-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N`W`7<BMT0W9;>'-ZB
MWRG?K^`VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@RZ+SI1NG0ZEOJ
MY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3TPO50]=[V;?;[
M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____VP!#``,"`@,"`@,#
M`@,#`P,#!`<%!`0$!`D&!P4'"@D+"PH)"@H,#1$.#`P0#`H*#A0/$!$2$Q,3
M"PX4%A02%A$2$Q+_VP!#`0,#`P0$!`@%!0@2#`H,$A(2$A(2$A(2$A(2$A(2
M$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A(2$A+_P``1"`"4`LL#
M`2(``A$!`Q$!_\0`'P```04!`0$!`0$```````````$"`P0%!@<("0H+_\0`
MM1```@$#`P($`P4%!`0```%]`0(#``01!1(A,4$&$U%A!R)Q%#*!D:$((T*Q
MP152T?`D,V)R@@D*%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA9
M6F-D969G:&EJ<W1U=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*S
MM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ
M_\0`'P$``P$!`0$!`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#
M!`<%!`0``0)W``$"`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1
M"A8D-.$E\1<8&1HF)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI
M:G-T=79W>'EZ@H.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZ
MPL/$Q<;'R,G*TM/4U=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1
M`Q$`/P#]1;G4OL\S1^7NQCG=C^E1?VS_`-,1_P!]_P#UJK:G_P`?C_0?RJK0
M!I_VS_TQ'_??_P!:C^V?^F(_[[_^M6910!I_VS_TQ'_??_UJ/[9_Z8C_`+[_
M`/K5F44`:?\`;/\`TQ'_`'W_`/6H_MG_`*8C_OO_`.M6910!I_VS_P!,1_WW
M_P#6H_MG_IB/^^__`*U9E%`&G_;/_3$?]]__`%J/[9_Z8C_OO_ZU9E%`&G_;
M/_3$?]]__6H_MG_IB/\`OO\`^M6910!I_P!L_P#3$?\`??\`]:C^V?\`IB/^
M^_\`ZU9E*,9%`%AO$^&(^S=#_P`]?_K4G_"4?].P_P"_O_UJYR_OH+!6>ZD5
M,Y*@GEOH*Y;4_%$UR"ED&@C/4Y^8_P"%5&-S&K7A#=ZG>ZE\0[;3%(EMR\N,
MB-)<G\>.*RA\601D:5_Y-?\`V->>$DDDDDGKFDK3D1PSQ<V_=T/1?^%L_P#4
M*_\`)K_["C_A;/\`U"O_`":_^PKSJBCD1'UFKW_(]%_X6S_U"O\`R:_^PH_X
M6S_U"O\`R:_^PKSJBCD0?6:O?\CT7_A;/_4*_P#)K_["C_A;/_4*_P#)K_["
MO.J*.1!]9J]_R/1?^%L_]0K_`,FO_L*5/BPA=1+IC*A/)6XW$?AMKSFBCD0U
MB:O<]BM?&<-['OMH5=>^)>GZ5-_PE'_3L/\`O[_]:O';:ZFM)`]M(T;CNIZ_
M7UKI--\5(X6/40$;IYB_=/U]*B4+;'72Q49:2T9WW_"4?].P_P"_O_UJ/^$H
M_P"G8?\`?W_ZU8,;K*@>)E9&'!!SFEJ#KZ7-W_A*/^G8?]_?_K4?\)1_T[#_
M`+^__6K"HH`W?^$H_P"G8?\`?W_ZU'_"4?\`3L/^_O\`]:L*B@#=_P"$H_Z=
MA_W]_P#K4?\`"4?].P_[^_\`UJPJ*`-W_A*/^G8?]_?_`*U36_B#SRW^C[=H
M_P">F?Z5SE6]/ZR?04`;O]L_],1_WW_]:C^V?^F(_P"^_P#ZU9E%`&G_`&S_
M`-,1_P!]_P#UJ/[9_P"F(_[[_P#K5F44`:?]L_\`3$?]]_\`UJ/[9_Z8C_OO
M_P"M6910!I_VS_TQ'_??_P!:C^V?^F(_[[_^M6910!I_VS_TQ'_??_UJ/[9_
MZ8C_`+[_`/K5F44`:?\`;/\`TQ'_`'W_`/6H_MG_`*8C_OO_`.M6910!I_VS
M_P!,1_WW_P#6I#K849:(#_@?_P!:LN1_+7(&:K/(7.6H`V#XB':#/_`__K4?
M\)%_T[_^1/\`ZU8M%`&U_P`)%_T[_P#D3_ZU'_"1?].__D3_`.M6+10!M?\`
M"1?]._\`Y$_^M1_PD7_3O_Y$_P#K5BT>M`#-2^)']G7LMN=.\SR\?-]HQG(!
MZ;?>JW_"UO\`J%G_`,"O_L:Y3Q+_`,ANY_X!_P"@BLL^O:MHQ6AYE3$5%-I,
MZW5OC-=Z<IDM_#OVN(#+%-0PR_5?+_E6`/VE\D`>&R23@#^T>_\`W[J*VL);
MC!`")ZFEN/"]B-]Q#!&MV%XE"@%C5KV2T:.:I+&O6%2R]%_D=#I_QKN;N/?<
M^'OLJD94-J&6/U'EC%6_^%P_]0C_`,G/_L*\X)Z4E-TX=B%C*Z5G+\%_D>D?
M\+B_ZA/_`)-__84?\+B_ZA/_`)-__85YO11[.(_KM?\`F_(](_X7%_U"?_)O
M_P"PH_X7%_U"?_)O_P"PKS>BCV<0^NU_YOR/2/\`A<7_`%"?_)O_`.PH_P"%
MQ?\`4)_\F_\`["O-Z*/9Q#Z[7_F_(](_X7%_U"?_`";_`/L*HZC\;KJR7?!X
M<-S&!\VV_P`,/P\O^M<+2AJ:IP6Z%+%UVM)V^2_R-\?M,#OX<(_[B/\`]KH_
MX:87_H7?_*C_`/:JXS5/#]KJ8+%1%,>DBCK]1WKD=3\/76F$ET\R(?\`+1.G
MX^E;0I4I=#SJN.S"GKSW7HO\CV'_`(:87_H7?_*C_P#:J/\`AIA?^A=_\J/_
M`-JKPS'%&*OZM2['/_;&-_G_``7^1[G_`,-,+_T+O_E1_P#M5+_PTPO_`$+O
M_E1_^UUX7BN^\%_#@:M;0ZAK#LMK+\R01\,Z^I/8?3FIG1HQ5VC?#X_,:\^6
MG*[]%_D>A:3\?[W6[GR-,\*23-_$?[1PJCU)\K`%=U;^-9'A4W-@D<I'S(ES
MO`_':/Y5RUCI]MIELL&GP1P0KT5%Q^?K4]<<^1_"K'TV'A7BOWL[OT2.JB\6
M>:#_`*+C'_37_P"M4R^)03AK<J/7S,_TKF;3HWX5;K)[G4MCHAK8896($?[_
M`/\`6I?[9_Z8C_OO_P"M7.JQ1LJ<&K4-QYAVL,-_.D,V/[9_Z8C_`+[_`/K4
M?VS_`-,1_P!]_P#UJS**`-:#53/,J>5MW'&=^?Z5H5@V/_'W%_O5O4`8>I_\
M?C_0?RJK5K4_^/Q_H/Y55H`****`"BBB@`HHHH`****`"BBB@`I0,TG0<]JQ
M]3\3P6>4M?W\HZ[?NC\>]-)LF4HQ6KL:TLL<$9>9U1!U9C@5SNJ>*PKE-+&[
MG'FL/Y#_`!K"O-0N-1?==R,P!X4<*/H*@QCI6B@CSZV+E+2.B,RYN9+N9I+E
MVD<D\L<U%2GJ?K25?2QR!1110`4444`%%%%`!1110`4444`%%%%`BY8ZK<Z>
M3]GE(4]48Y!_"NIT[Q';7VU)3Y,Q_A)^4_0UQ5`XS[U+BF;TJ\H:'I=%<3IO
MB*YL"$D8SQ=-C'D#V/\`C75:?JUMJ2`V[X?',;<,*AP:/1IUX36^I<HHHJ#8
M****`"K>G]9/H*J5;T_K)]!0!:HHHH`****`"BBB@`HHHH`****`"BBB@!ES
M_JQ56K5S_JQ56@`HHHH`****`"@#)XHIK-@\4`<=K]N]QK=P(@3]S)QP/E%)
M;Z:D6#+\[>O85JZC_P`?LA/?'\A5:MNAYSI+F;`<#`IDOW&_W33Z9+]QO]TT
M%2V..-)2M25NMCQY;A1110(****`"BBB@`HHHH`*&PP(8`@]11136@&%JGA.
MWO`9+'_1YO3/R-^':N2O=.N-/EV7<;(W8GH?H:]*ID]O%=1&.XC1T/4,,U<*
MC3U.6KA(SU6C/+Z]]\%?\BII7_7LM>5ZIX-*AI-,?/<Q.?Y'_&O5O!T;1>&-
M-212K);JK`CH:6(:<4S?):,Z>(ES=OU-FBBBN0^H+5IT;\*MU4M.C?A5NLWN
M4M@J6V_UP^A_E452VW^N'T/\J0RW1110!8L?^/N+_>K>K!L?^/N+_>K>H`P]
M3_X_'^@_E56K6I_\?C_0?RJK0`4444`%%%%`!1110`4444`%+24HZT`<SXKU
M1PPL[<E1MW2D'KZ"N;"@=!6AXA_Y#MR!TPO_`*"*H5NMCQZ\W*;N%!.!D]J*
M#R#3,C(8;68'J#25<N;8G+)][J1ZU4((ZT`)1110`4444`%%%%`!1110`444
M4`%%%%`!1110`4Z.1HI`T;%64Y!'44VC&:!IV9WFB:E_:=BLCX\Q?E?'J/\`
M]=7ZYWP;Q#=#MN7_`-FKHJPEN>Q0ES4TP_$#ZFN0OOC#X"TR\GM-1\<>#[2Z
MMI6BG@GURVC>)U.&5E+Y!!!!!Y%97[0?C^]^&/P=\3>(]%@DGO[*V5+9E7<(
M))'6-9B/1"X<_P"[VZU^2$LTD\KRW#O)+(Q9W=LLS'J2>YS7#B\7[%I)79]W
MPKP@LWHSK5:CC%.RM;5[L_:RQOK;5+*"\TV>&ZM+J-98)X)`\<J,,JRL.""#
MD$<5I6`P9"?3%?)'_!/[XBW^O_#G6/#VMB3[+X4N(_LE[*0$$4^YO)+$]596
M/LKJ.,"OK:TO;-R(K:[MYI#D[4E5B?P%=5*I[2FIVW/E\XP7]G8^IA)R5XO[
MUNOO5BW1115G`%%%%`!1110`4444`%%%%`!1110`RY_U8JK5JY_U8JK0`444
M4`%(3BE'6FMUH`0\G-!Z44'I0!AZC_Q^2?A_(56JSJ/_`!^2?A_(56K7HCB>
M["F2_<;_`'33Z9+]QO\`=--$RV..:DI6I*W6QX\MPHHHH$%%%%`!1110`444
M4`%%%%`!1110`HKOM$&_2+;=S\@K@5ZUUOA[7(#;16MPPAD0;5+'AN>*BHKH
M[L%)*;N;+*5//3L:;4LH^7Z5%61ZY:M.C?A5NJEIT;\*MUF]REL%2VW^N'T/
M\JBS5BWB((=ACT%(98HHHH`L6/\`Q]Q?[U;U8-C_`,?<7^]6]0!AZG_Q^/\`
M0?RJK5K4_P#C\?Z#^55:`"BBB@`HHHH`****`"BE^E<]XC\;Z9X=0K/+Y]UV
MMXF!;_@1Z+347+1$5*D*<>:;LCH.N,<YZ4HZUX7K_CS5M>D(:<VMMGY88&*C
M\3G)_E[5=\.?$G4='V0WV[4+4'[KM^\0?[+=_H<UM]7E8\Y9O0YK.]NYUOB+
M_D/77T7_`-!%4*9-XCL?$.J7$VFS!C\H:)OE=?E'53SCWI]5RM+4PG.,I.47
M=!1112)#&:BFMEE'0`^HJ6B@#-FMVB'(R/45#FM=ER#[U7ELU;++P>X]:`*%
M%/>)HSAQBF4`%%%%`!1110`4444`%%%%`!1110`4444`=3X-_P!3<_[R_P#L
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MX&^-`I`/3`3/S*:\^\#>,K_X?>+--U_1&VW6FS"3;T$J='C/LRD@_6NI\/Z2
M_P`0?AW<V<]S:6=UX0G22RO;Z800FVN7.^W,C?+N$N)$!_O3>E3^#OA?!'K8
MO/$&HZ!JVG:7;S7]SI^F:M%//=K!&TGE*JG.&V88CHNX]J]_#TZ.&H>QZ1T]
M3\8SG&9EG6:O,FVY5&I)]O+Y-?J??-C\5?"EWI]E=7>OZ/IK7UK%<K;7M_%#
M-&LB*ZAT9@P.&'&*Z+3=5LM9L4O=(N[6^LY03'<6TRR1O@X.&4D'!!'7M7Y3
M:_KMYXFUN]U75I/,O+^=I9F`P,D]%'8`8`'8`#M7U%^Q!\0KUGUOP;=I-/9+
M;OJ%I*!D6Q!"R*3V#%E(]P?6O+Q64>RHNI&6W3^NQ]OD?';QV/CA*M.REHI*
M^_2ZZ7_`^L](UO3O$%I]JT#4++4[7<4\^SG69-PZC<I(R/2IK/4+748'FL+F
MWN88G>-Y(9`ZJZ$AU)'&0001V((-?-/[-[?\*XT_P/G,7AWXDZ1#R>4M]9AC
MQ_P'SXAZ\O%[U/IL9U[0/#_@^ZDFBTCQ7\0M?35?)<H;BW@N+R<V[,.0KLBA
ML<E=P[UXQ^CGNNF_$;PIK.KG2M(\3:!>ZF"1]C@U*)Y21U`0-DFMFTU&TOYK
MF*RNK>XELY/*N4BE#F%\`['`/RM@@X/."#7(^,?A)X6\4^#YM&.D:=IZ0PDZ
M?<6=ND+Z?*H_=RQ,N"I4@'@C..>*\K^!_BB\7QEX;U+66;;\4_"L-Q+*W_+7
M5;!1'*P'0>9`5?C^Y0!]`OJ5G'J$5A)=6R7T\;2Q6K2J)712`6"YR5!(&1QD
M@5BR?$KPC%K(TB7Q3X=352_E_8FU.$3;LXV[-V<Y[=:\*\::M<^(?$'C7Q!I
MUS/:QWFLZ9X!TZ^@?8]K`URGV^1#V8O*8PPZ&,>E>W-\*/!A\+_\(X?#.C'1
M?*\LVAM5QC&,[OO;^^_.[/.<T`=/<3Q6D#S7<D<,,2EGDD;:J@=22>U8>C?$
M'PMXBOFLM`\2:#J5ZO6WM-1BFD]_E5B:\(\((?'NI^$O`7B^>75=$\/SZX;I
M+H9&K?V?>);6BR_WU59=Q!R&903G%>^1Z)X;T.]T^2/3]$L+T%H-/9;>**0$
MH24BX!^XK9"]@>PH`JW7Q,\'V5U+;7GBOPU#<0.8Y8I-6@5D<'!5@6X((P0:
MUQKNFMJW]E)J%BVIB'S_`+$+A?.\O^_Y>=VWWQBO$/A=XETFUM=8M+[P;KVJ
M3GQ9K"M?VWA\W,)W:A-_RUQT7.#Z8/I6?\1]&O8/BYXM\9>&(VFUWP+IFC7\
M4"#FZM&^V"[MO^!Q98?[4:4`?0-UJ-J+M;$W-O\`;6B\X6_FKYGE@XW[<YVY
M(&<8S3:\RM=7M/$'QVT74](G6YL-1\`O<VTR])(WO(RI_(BO3:`"BBB@`'6F
MM]XTX=::WWC0`E!Z44'I0!AZC_Q^2?A_(56JSJ/_`!^2?A_(56K7HCB>["F2
M_<;_`'33Z9,0L3LQP%4Y-,F6QQS4E*:2MUL>.]PHHHH$%%%%`!1110`4444`
M%%%%`!1110`9Q1DT44`2W/B^[\.67FH!<P(Z@Q2$_=)&<'M71^'?&>F^)$Q9
MRF.XQEK>7`8?3L1]*\^\6?\`($E_WT_]"%<-&[1.KQLR.IRK*<$'U%:*C&<;
MF,LRJX>KR[KL?4%F<J_L16A'`TG^R/4UP/P6UV]U^UU-=6F-Q]C,2Q,X&0&W
MYR>_0=:]*["N"<>631]/AJ\:U)5([,9'"D62!DGN:?114FX4444`6+'_`(^X
MO]ZMZL&Q_P"/N+_>K>H`P]3_`./Q_H/Y55JUJ?\`Q^/]!_*JM`!1110`4444
M`%5=5U6VT6RDN]0D\N&/J0,DGL`.YJV.M<3\7?\`D6(O^OU/_07JHJ[2,,34
M=.C*:W1R_B7XHWVIEX-'#6%L<C?NS*X^O1?P_.N(8EV+.<L3DD\DTE%=ZBH[
M'R%7$5*KO-W"BBBF8',ZG/)::L\MK(\4B$%61L$<"NK\/_$N2,+!KR-*N?\`
MCXC'('^TO?\`#\JY#6_^0E+]1_Z"*HCK6W+&4=3&%>I2DW%GT#;SI<PI+`P>
M.10R..C`C(J2LSP;;2OX:T[Y=H-NN"W&:VS8R8RNT^V:X)*SL?2TTY13MN5Z
M*4JR$B0%3GO24AO3<****`$90PP<54FLN\9'TJY10!D$%3A@0?>DK4>!9!AN
M:J2V;+DIR/2@"M12D8-)0`4444`%%%%`!113D1I&PBD_TH`;4L<#2'Y>GK5F
M"R`YD.3Z5:`P.*`.@\$6RI#=MU(9>OT-=0.U<[X-_P!3>?[Z?UKHSUK&:]X]
M;#?PD0WMI!J-I/:WL2S6US&T<T3C*R(PP5/L037Q?KW["GB<ZW>_\(SK/AY=
M),[&R%Y<3B98B<JK@1$;@"!D$YQ7VK171AL95P]^3J>;G&08'->3ZU%OEO:S
MMN?G%\9_"-_\)+/2/`]XJLP3^U+^\BSY5].^Z-=A(!*1HI49`.YY#C#"O._#
MVO7OA;7+'5M&E\J]T^9986QD9!Z$=U(R".X)%?H9^T%\"X_C7H5A#:74.FZK
MI=P7M[N2,NIC<`21L!S@X4@]BN.YKR;X??L23^'?&.EZGXLUO3=4TW3YO/DL
MXK=U,[+RBG=QMW;21W`QWKV\/F5'V%ZCUZKN?EN:\&YDLSY<+!NGIRRNO=6F
M]]=#D+[]C'Q-XFN/[8\-76A:/I>JQQWEOIVHSSK-9"1`[0.%B8?(Q9.O(4$\
MU]!?L\?`\_!KPA>6^IS6EWKFJRE[RXMLF,(N1&BEE!*@$MT!RY]J]<Z#`&`*
M2O&KX^O6AR2>A^CY;PIEN`Q'UFE%\_=O37=I=#RFQ^#-Q<?`+2_`NLW-O#K.
ME6$0M+^U9BMK?0MOAF1BH;"R`=AD;AWJEH_P6UR7X=65AK.JV&F^,--\0W6O
M6>H::'GMX;F6>63;M<(SQLLS(R\<'J<<^QT5QGTAYGJVE_$_Q7I,^BZE_P`(
MCX<AO(C!>ZMIM_<74XC(PYMX7AC5'(S@L[;<YPV!3_'/PLN9O!WA:R^&C6%A
MJ_@:[M9]#^VLRQ%(U\IX9&56;:\3,#@')`KTFB@#S'1O@G!!\$;;P+JU](+S
MR1+<:G;/N=;_`,WSS<HQ`)(G^8$X)``/>I5?XLC3_L+0>`A>*OE_VT+RY8$=
M/-^R>2/GQSL\X+N[XKTFB@#RNZ^"<VD^'_"__""ZN;7Q-X1>XEM=1U!&F34&
MN#NNDN0#G;*YWG:<JP!7CBGW'ASQYXI\4^$+WQ;8^%-/M?#.J/>S2Z?JL]P]
MPS6TT&U(WMT"C,V>7.,=Z]1HH`\M\):!X^\$VFIV%AIO@N^L[C6;^^AFFUNY
MA?9<7,DP#(+1AD!\'YCTZ]ZZC2/"MY8?$CQ/X@N'MC9ZU8:=;P(K$NKVYN-^
MX%0,?OEQ@GOP*ZJB@#Q_X:_!G5_`'Q*O]0-WIDOA*WL+BST*UC9_M-M%/<+<
M>4X*A=B/YBJ0Q.-N:];D@S_J_P`JEHH`I$%3AA@T5=*AAAA5>2W9>5Y7U-`$
M0ZTUOO&GXP:8WWC0`E!Z44'I0!AZC_Q^2?A_(56J76+B.VN9&F8*!C^0KG+W
M77ERMH#&O]]NI_PK=1;2/.J58P;N:MYJ$-DO[QLOV0=36#?ZK+>`J/W<1_A7
MO]35-B6R222>22<YIM:*"1P5,0Y:=`HHHJC!NX4444""BBB@`HHHH`****`"
MBBB@`HHHH`****`,;Q;_`,@27_?3_P!"%<*.E=UXM_Y`DO\`OI_Z$*X4=*ZJ
M7PGD8W^+\O\`,]D_9]Y@UW_>M_\`VI7K/:O)?V??]1KO^];_`/M2O6NU>=7_
M`(C/KLJ_W2'S_,****Q/1"BBB@"Q8_\`'W%_O5O5@V/_`!]Q?[U;U`&'J?\`
MQ^/]!_*JM6M3_P"/Q_H/Y55H`****`"BBB@!1UKB?B[_`,BQ%_U^I_Z"]=L.
MM<3\73_Q3,7_`%^I_P"@O5T_B1RX[_=I^AX_1117H'Q@44^*&2XD"0J78]A6
M_I_AI0`^H$,?^>:GC\:3:1M2H3J/1'G]SI-SJVJS"SC+*&`9SPJ\#J:Z32?"
M-M8;9+K_`$F=>02/E7Z"NCNXTBF98E5%'0+P!Q_]:HAT-)U&]C>GA80=WJSM
M=*&-+M<8`"<`=JM56TO_`)!=M_N59KD;N?14_@0UXDE3;(`:IRV#1_ZK#`]N
MXJ]0#BBX3IJ1DY]>"*,UI36T=P/G^5O[PJA-:O">F5]157.65)IC**0$'H:6
M@R"BBB@"*6V249.0?451E@:(\\CU`K3I"@/6@#(HJ_+9J^=GRD56-K("1M)^
M@H`AI5&XX'6IX[-V^\"H_6KD4"Q#Y<Y]:`*L5D>LGY5;2%4&$&!3Z*`"BBB@
M#IO!O^IO/]]/ZUT9ZUSG@W_57G^^G]:Z,]:RGJSU\,OW*$HI<48J#8,=?;FD
M]?;K[50U_2;77-%N['4K:*\@FC),,@R&8<KQZ@@'->=_\(?J>G_!CP]IGAVV
M_L_6Q/HD]X#$6*2I<VQN))%5U+X57+#<,A3SSP`>J`%L8YR,C%)7DVI>'_%+
M^!?BO:Z@_P!NU;5&N#ILEG`\"SYTRVC3RD,CL/WBLOWN64GC-=OX!L$TWPW#
M;QV\-LR2.76'3)-/0L3G*PNS,.W))R030!T8&3@=?2C!':N$D\*WUS\89];D
MCLO[-M=*LXX'N+1I)#+NN]_DR"0",@-'NRC9!'3BLF?3M;/B;^SDL=3VCQ?'
MJHO,?Z.UDL"Y/F9P/G!3R_O9.=NWYJ`6IZA2XYQW%</<>";1_BM::R-,B:)=
M,FDDN]O'VL2Q>6W^_LWX/ID9[5D7EIK`\1W^EQ:9J;+>^*K+48+P+_HZV4<-
MOYF9"<#YX9%\O[Q+`X(;-`'IXY&1TH"E@"O.>F*\D\0>$-=G^*T&MVUNO]EQ
M7]BLDT43?:A&(Y`Q1]^/*WF-9$*G*L2#\HK7@T2X7XR7VHWMK'):O!"MG,^E
MRRL#Y3!RMP'V1C+-E2A))Z\T6`]$`)Z4F<G`ZUS?Q%LM1U#P=?0:"+F2Y=X&
MD@M9O)FN+=9T:>*-]R[7>$2H#N'+#D=1B>`M)>UU_6Y]$TR^T7PU/96RV]E=
M*T&^[4R^=*D)YC!5HE)P-[*6`XW,`=^.1D<BBN'^"_A2]\(_#W2;77([*+4I
M+.W>Z6WM&@82^2@82YD??(&#9?(!/85W-`"444N*%J`E%%%`#3&K9XP3WJI(
MC*YSS]*NU#)]YOK0!5Z].M.$18?,.#4H4#H!3AUH`\V\8$_V_<J22%V8!/3Y
M!6+6SXP!'B&[S_L?^@+6-79'8^=Q'\67J%%%%,Q"BBB@`HHHH`****`"BBB@
M`HHHH`****`"BBB@`HHHH`QO%O\`R!)?]]/_`$(5PHZ5W7BW_D"2_P"^G_H0
MKA1TKJI?">1C?XOR_P`SV/\`9]_U&N_[UO\`^U*]:[5Y-^S^I6VUMB"%9X0#
MC@D!^/UKUGM7G5_XC/KLJ_W2'S_,****Q/1"BBB@"Q8_\?<7^]6]6#8_\?<7
M^]6]0!AZG_Q^/]!_*JM6M3_X_'^@_E56@`HHHH`****`"N:^(6AW.O\`A\PZ
M<HDGAF658^A<`$$#WYKI:1G"''4]Q33L[F=6FJD'![,^;IH)+>=H9XWCF4X:
M-E(8'TQ6MI_AV6?Y[L^2G]TCYC_A7L^J:1:ZLX>ZA1I$4A)0,,H]`:Y?4_#5
MQ8C?#F>(=UZK]1_A74JZ:MU/"EE7LGS/5&!;6<-I'LMD6,'J1U/XU/1VS2JI
M=@J`DGH!2UO=EI):(R;[FX;\*9;V\ES)Y<",[GL.WU]*WE\-22W)>_)B3@[`
M/F/^%;-O:Q6D02W144>G]30YHJ&&<G>6@EG";:SAB<@M&N&QZU+1161Z$596
M"BBB@84`X_&BB@"O+9I)EH\(W\ZIRQ/`V)!QZXXK4H8!EPP!![$9JDS&I14M
M49`8'I2U:FL!DFW/_`355_D;:X(;T(IG+*$HO4****"`HHHH&%%%%`!1110`
M4444`9^O?%C2OA=I\?\`:-MJ&I:EJ]PL&FZ9IT/FW%VXZA5XSC*_F.#72_#7
MXBR^/X-0^W^&O$'AF[TV14EAU:W\OS"P)!1OX@`.>.,CK7G?C7P1XEU37/#7
MB_X=Q6=_K'@^ZG)TV[E$2W<5Q&$<*YX5@JD<D?>SG(P?1OAWK?C776U"?X@^
M'=.\-VVZ-=/M8=1%U-C!WF5E^3&=N,$'J".`3K4A#V*DK7]=5KV,,'7Q+QKI
MU&U!/1*%XM<M[N=M'S75KKIIK<R]7^-VC:-\6=.\!SV]T]]?QJ3=KM$,$CJ[
M)$V3G<P08_WAZ&M#XN_%*R^$/A,:]JUG=7UL;N.W,=L5#98$@_,<8^6O!]>^
M!7Q'U^3Q'XRANK>QURX\10ZE8:%)%"\D@MF*VQ^T^9A=L4C_`"]#CZ5ZE^T/
MX/U[XC_#;3;/P_IHEU`ZI:W5Q:2SQCRD56W@LS;3@D#@G-5*CAU.FD].IST\
M?FD\-BG*DU)7=/W>CO96UNU;5/77;8Z/1?BWI?B+QS8>'=&AGN%U/P\NN6]^
MK+Y1A:0QA",[@V1GVJA\1?C79^!==M=`TS1-:\4^(KN`W']FZ3!YCP0Y(\R0
M_P`()'OVSC(SQ/PK^"&L_#?X[:C?6R^=X-31YH-(E,RDVJRSK-]FVYW#:YEP
M<8((.<G`T_&WA#QCX1^+LGCWX<Z3:>)8=6TM=/U'3)+Q;26,JPVR([_+MPB\
M=<YXYR!TL.JMD[JW>UWYOH7]<S26!<YP<9\]G:-VH]TOM:[/71WUL>D>#/&/
M_"8>%H]9?2-6T5B9%DL=3M_*G1D)#9&>F0<'O7$_##X]O\4]0LAIW@[Q-9:7
M>K*4U:YB4VH*9!&\'J64K]:[+P;=>)M7\*-+X]TW3]*U><R[;.RN?.6*,D[%
M9NF\`X."1D9XS@>'_LV?#+Q+\--3L(?$7@.:TN989X;W7?\`A(TE18RQD4"U
M5B,DJBY'/?N:B%.DX5&]UMK_`,'7\2Z^*QL<3A(POR23YGRZ[QM=<KY;ZZ/E
M]3T3XE?'BW^'/BR+04\-:YK]VVE_VE)_9JH_EP!W5B02#@;"2>G-=UX-\66'
MCKPOIVO:$TC6&IPB2+S``Z\D%6`)`(((/)Y'>O%OC/\`!77?B5\4C>Z;/=Z;
MIO\`PB,EG'?V]ZL.;OS9&6*1<[FC8.`P`P0>M>H?![3;_1?AKH.FZ]I$6AW^
MG6JVTUI%,LJY3C>&4D'=][KG).<]:*U.BJ,91^+J:9?B,QEF=:%>+]EKRZ66
MC75+\]^FS+?Q!\977@C1(]0T_P`/ZSXD=[@1/:Z7$'DC4JS&1A_=&T#_`(%7
M,_"7XV-\67#V/A77M+TQ[9YH=4NT4V\S)($,:L.K9+<?[)KT>[C:6TG2,?-)
M&RCG')'_`-:O/?V=O!VK>!/A!HFB>*;;['J-HUQYL/F+)LW3R.OS*2#PP/7O
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M6^IWT:BWGPRJ$5AU)R3_`,!-9?Q`_:+M/`7B_4]#?PQX@U?^Q;.*\O[JP1'2
M"!@#O8$Y`&>2<"N>_9G\!Z]\.I?L6N^")=$DGLMM]K!\1)=I<.C955MU)\O.
MYNAQQ61\8/@)XG^('Q%\9ZII;W=C;76@PIIDL-^D4=]/'LW6\J[@Q5@&`)PN
M<$GC%:JCAO;R3:Y>FOGY,X:N,SC^R:52G%NLWJN76W*W:SC'2Z2O;RNV?0^@
MZY:>)-!L=8TMRUEJ5K'<P/(NT^6ZA@2.QP:XGX1?''1?C#-K4>@VUS:G1YE7
M-PR_Z1&Q8+(F#T^1LCMWJ'6+/Q*_P%ET[P]X>&G^)'T5;"+28;B)%M&($1V/
MOV[53<ZG=G`&>>*X7X:?!CQC\*/B-X>O?MUIK^CSZ*VE:B]O:1V9L4CP\1*^
M83,2Y(W@;L9S6,:5+DFVU?6VO;_,]&KC<?'$X90IMP:7.U'K+1;ZJSU:MHM[
M'9_$KX[P?#SQ8F@1>&]>U^\.E'4Y#ID:OY<`=U8D9S@;,D^];<GQ5L;GX4GQ
M[X?L;W5M-%H;K[-"56;8I(D&"<93#9&?X3BN#^)OP6U/XB_&ZVU!KO6-)\.#
MPP;*?4-)OXX)6F\Z0F`@[CL9'Y^7!XKUSPKX3T[P;X8L=`T.'9IUA`8HD<[B
MP))8MZEB23ZDFE46'C3A;?J:8669UL57532GJHMI7OI9K2[6^][]#D?"GQNT
MKQQXML-$\*V=Y?+<Z-'JEU>J5$5BL@^6*3G/F$XX]_8UZ,>O'2O(_P!G?X93
M_#:P\5Q:CI<.FR7_`(AGDL_+E20O9*%$`RI.`,O@'D;CQS7K=8XA4U.U/8Z\
MGGBYX6-3%?&^EK6\N_GKW"H7^^WUJ:H7^^WUK$]0;2TE%`')^-="DN"+ZT4N
M47;*H&3@="*XG\#7L58>L>$[35-SQ@6UP?XX^C?45M3J=&>=B<$Y-S@><XQ1
M6EJN@WFD,?M49:/M*@RI_'M^-9P&:W33V/*E"479JPE%!&**"0HHHH`****`
M"BBB@`HHHH`****`"C&:,5>L=(GOB"B^7'_?8<'Z4-V*C!MV*./4@'ZT$8-=
MC8Z5!8K\J[Y"/F=N_P#A2W>EV]ZI$B`,>CJ,$5G[17.KZG*V^IYKXMXT67/]
M]/\`T(5Q=C87&I7<5K80R7%Q,VU(XUR6->T7'PWEUP?9KBZ%O;,RL9`F7(!Y
M`!XS[UV_ASPEI?A6W\O1[98V8?O)F^:1S[M_3I6T<1&,+'$\IJUZW-+2/];%
M7P%X7_X1+P[!:2$-<N?-N&7H7('`]@!BNAI:2N&3;=V?34Z<:<%".R"BBBD6
M%%%%`%BQ_P"/N+_>K>K!L?\`C[B_WJWJ`,/4_P#C\?Z#^55:M:G_`,?C_0?R
MJK0`444O\J`$H9@HY/X4QI>H`_&HCR<GDT`/9R3P<"F444`%'7KVHHH`R]1\
M.VNH-OP89/[R=_J*FT[1[;3`#"FZ0=9&.6/^%7J*?.TB%2@G>VI@:IQ>R@>H
M_D*J5;U7_C^E^H_D*J5HC"6X4444""BBB@`HHHH`****`"DDC25<2<^_>EHI
MW$TFK,HRV+)EHLNH[>E5\_7BM8$BHYK>.<?,"&]133.>I1[&;FBGRV[0.`W(
M/1J93.>2LPHHHH$%%%%`!11FBBP'3>#<>5>9_OI_6NCKG/!O^IO/]]/ZUT9Z
MUE4W/6PW\)!DX^M`)!X.*2BH-P[8XI<GVI**`%SD\_K1T&,"DHH`7<:"Q/4D
MTE%`!2YI**`#Z@?E2]1_/WI**`%SQU/YT9)__7244`*"1CMCICM1DXZGFDHH
M`7/K2444`+G-)12T`%5W/SM]:KZMKMEHD>Z^F4-_#$OS.WX?XUS4_B275HR\
M"F"%R1MW98@$CDU:@VKF4Z].#LWJ;E]K,%H2F?,D[A3T^M4U\3#/S0MM]G&?
MY5@YH!Q5\B.66(FWH=E::A!>)F%_F[J>"*L5PZ2-&P:,E6'0@]*V+/Q"R@+>
M@D=G7K^(J7#L;0Q">C-YXTD0I(JLK=01D&N8UCP5%-NETQA"YY\MLE3]/3^5
M=+!/'<1AH'$BGN*EJ5)Q-9TX5%JCR.]LI[";RKN-HW'KW^GK4!&*];O+&#4(
M3%=QI(A[,.GT/45QVL^"I+?=)I3&:,G_`%3??'T]:WA4ON>57P4H*\=4<K13
MI(FB<I*I1UZJPP132,&M#A:L%%%%`@HHHH`***?%$\T@2)2S-T`%#=AI7&XJ
M:ULIKQ]L"%O4]A6Q8>'#Q)?G'I&I_F:W(XTA39$JH@_A48%0YHZZ>$;^(R[#
M0(8,/<_OG[`_='X=ZUJ='$TIP@)J_!IZJ`9AN;L,\"L92OK<]&E225DBI!:O
M<'Y>%'<U?@LTA&2-S>IJP!M&!Q14.3.B,$@QZ_SJ6.X9.#\R^E144BR^D@D^
MZ1GTI:H`D=#CZ5-'<G@.,CUH`LT4`AAE2#]**`"BBB@"Q8_\?<7^]6]6#8_\
M?<7^]6]0!AZG_P`?C_0?RJK5K4_^/Q_H/Y55H`*;*2%&/XJ=3)ONK^-`$5%%
M%`!1110`4444`%%%%`&#JH(O7)_BP1^0JG70WUDMW%\IV2*/E/;\:PY[=[=L
M2*1Z'L?H:TCL<THM,BHHHIDA1110`4444`%%%%`!1110`4444`-F031,OJ.*
MREX'-;"]:QT^Z/I5(Y*\4FA:***I;F`R:9($+RL%11DL2`!7*:SXZCBW1:0J
MROT,K_='T'>H?B"[JUH@=MC%SM[9&T5QW2NFG25KGGXC$SC)QB='IOC>\MY?
M^)A_I,1.3D`,OTQ7::;K-KJL>^SD#$#YE)PR_A7E%:_A[2[BXU"UD0F&/S5_
M>=\9Z"B=-:F>'Q%1.VY[OX.B86MQ(1A9'&W\.O\`.N@-16UO':P)%`H5$&`!
M4E>?)W9]=3AR040HHHJ2PHHHH`****`"BBB@`HHHH`****`"BBB@`HHHH`*4
M]*1B%&7(4`9))KD];\?VUGNBTD+<S=/,S\B_X_YYJE%O8RJUHTHWDSI[N\@L
M(&FO94AC7J6.*XC6_B!+*Q@T)"`>/.<98_1>U<KJ.I7.JW!FOI6D<]!T`]@.
M@K7\'(IFN6*C>H7:WIG.:W4%"-V>;+&3K5%"&B_$;9^&[B_D\_5WD0.<X9LN
MWU]*Z--'@%LB6X,6T8'.?SJ7-68ON`5+DV=5*A3@N]_O,.XM)+8_O%^7LPZ&
MH:Z1U#(P.""*YS&,^QH1G5I\K$H!Q113,R6WNY;5]T#E3W]#]:WK#Q!'*`EW
MB)^@/8USE`XJ7%,N%64-CNE(=05((/0@TM<?9:E-9']TP*=T8<&N@T_5X+T!
M0?+D/\#\?D>]9N+1VPK1EOH-U70K35T/VF/$F.)$&&'^-<3J_A2[TS=)&#<6
MX_C1>0/<5Z1T-)BG&;3,ZV%IU-]SQ['I2$8KT36/"-KJ6Z2#;;3DYW*ORL?<
M#^8KBM3T2ZTB0+=Q_(?NR+]TUO&I%GDUL+4IO78H44459S`.M=%X9A3R9I<#
M>6VY]L9_K7.CK78^&-,F6T)G1HED?<N\8)&!SBHJ-)'7A(-U$70"S849/H*M
MPV!)!F./]FKL5ND(&Q0#W..34E<[EV/8A3MN-1%1<*`!3J**DU"BBB@`HHHH
M`****`)K8D2X[$5:JI;_`.M'T-6Z`"BBB@"Q8_\`'W%_O5O5@V/_`!]Q?[U;
MU`%&[@C,N60$D<G)J'[/%_SS'YG_`!HHI`'V>+_GF/S/^-(;6%NL8X_VC_C1
M10`GV.#_`)YC_OH_XT?8X/\`GF/^^C_C110`?8X/^>8_[Z/^-'V.#_GF/^^C
M_C110`?8X/\`GF/^^C_C1]C@_P">8_[Z/^-%%`!]C@_YYC_OH_XT?8X/^>8_
M[Z/^-%%`!]C@_P">0_[Z/^-,DTZVE4K)"K`]BQ_QHHHNP:ON5_\`A'M._P"?
M4?\`?Q_\:/\`A'M._P"?4?\`?Q_\:**+L7*NP?\`"/:=_P`^H_[^/_C1_P`(
M]IW_`#ZC_OX_^-%%%V+E78/^$>T[_GU'_?Q_\:/^$>T[_GU'_?Q_\:**+L.5
M=@_X1[3O^?4?]_'_`,:='X=TUG`-J,'_`*:/_C11338<J[%G_A%=+_Y]?_(K
M_P"-'_"*Z7_SZ_\`D5_\:**=V'*NP?\`"*Z7_P`^O_D5_P#&C_A%=+_Y]?\`
MR*_^-%%%V'*NP?\`"*Z7_P`^O_D5_P#&H1X)T4=+/_R-)_\`%444KL3IP>Z#
M_A"M&_Y\_P#R,_\`\51_PA6C?\^?_D:3_P"*HHH4GW%[&G_*ON*.H_##PSJQ
M0ZAIOFF/.W_295QGKT8>E4_^%,>#O^@/_P"3D_\`\7115>TFMF2\-1;NX+[D
M/C^#OA")U=-'&5Z9NYB/R+U>C^'/AV)U:/3\,A!4_:)>,?\``J**/:3?4%AJ
M*V@ON1N?V=;_`///_P`>/^-']G6__//_`,>/^-%%2;!_9UO_`,\__'C_`(T?
MV=;_`///_P`>/^-%%`!_9UO_`,\__'C_`(T?V=;_`///_P`>/^-%%`!_9UO_
M`,\__'C_`(T?V=;_`///_P`>/^-%%`!_9UO_`,\__'C_`(T?V=;_`///_P`>
M/^-%%`!_9UO_`,\__'C_`(T?V=;_`///_P`>/^-%%`!_9UO_`,\__'C_`(T?
MV=;_`///_P`>/^-%%`!_9UO_`,\__'C_`(T?V=;_`///_P`>/^-%%`!_9UO_
M`,\__'C_`(T?V=;_`///_P`>/^-%%`%/4?#&G:M$([^!Y(QSL$[J#]0&&?QK
M._X5MX<_Z!W_`),R_P#Q5%%--K8SE2IRWB@_X5MX<_Z!W_DS+_\`%58L_`^B
M:>6-I9>67QN_?R'./JU%%/FEW!4::=U%?<6O^$9TW_GV_P#(K_XTJ^'-.3.V
MWQG_`*:-_C112NR^5=AW_"/Z>1_Q[_\`D1O\:K?\(;H__/H?^_TG_P`5111=
MB<4]T)_PAFC_`//H?^_S_P#Q5'_"&:/_`,^A_P"_S_\`Q5%%',^Y/)'L'_"&
M:/\`\^A_[_/_`/%4?\(9H_\`SZ'_`+_/_P#%444<S[AR1[!_PANC_P#/H?\`
MO\__`,52CP=I`.1:$$?]-Y/_`(JBBB[*4(]B['HUG$@1(CM7IF1C_,T[^RK7
M_GE_X^W^-%%(H/[*M?\`GE_X^?\`&F2Z+931LDL"NC#!!)(/ZT44`9)^'?AX
MG/\`9_Y7$O\`\51_PKKP]_T#S_X$R_\`Q5%%5S2[F7L*7\J^XEM?`>A6<PE@
ML%$B]"TKMC\V-:7]C6?_`#Q_\?;_`!HHI-M[E1IPCLK!_8UG_P`\?_'V_P`:
M/[&L_P#GC_X^W^-%%(L/[&L_^>/_`(^W^-']C6?_`#Q_\?;_`!HHH`/[&L_^
M>/\`X^W^-']C6?\`SQ_\?;_&BB@`_L:S_P">/_C[?XT?V-9_\\?_`!]O\:**
M`#^QK/\`YX_^/M_C1_8UG_SQ_P#'V_QHHH`5=)M$.5BP?]]O\:?_`&=;_P#/
M/_QX_P"-%%`!_9UO_P`\_P#QX_XT?V=;_P#//_QX_P"-%%`"QV$$3AT3##H=
(QJQ110!__]D_
`
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>g911894g80l95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g911894g80l95.jpg
M_]C_X03Q17AI9@``34T`*@````@`!P$2``,````!``$```$:``4````!````
M8@$;``4````!````:@$H``,````!``(```$Q``(````>````<@$R``(````4
M````D(=I``0````!````I````-``"OR````G$``*_(```"<0061O8F4@4&AO
M=&]S:&]P($-3-B`H5VEN9&]W<RD`,C`Q-3HP,SHP-"`Q-#HQ,CHR,0```Z`!
M``,````!``$``*`"``0````!```"RZ`#``0````!````0@`````````&`0,`
M`P````$`!@```1H`!0````$```$>`1L`!0````$```$F`2@``P````$``@``
M`@$`!`````$```$N`@(`!`````$```.[`````````$@````!````2`````'_
MV/_M``Q!9&]B95]#30`!_^X`#D%D;V)E`&2``````?_;`(0`#`@("`D(#`D)
M#!$+"@L1%0\,#`\5&!,3%1,3&!$,#`P,#`P1#`P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`$-"PL-#@T0#@X0%`X.#A04#@X.#A01#`P,#`P1$0P,#`P,
M#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,_\``$0@`#P"@`P$B``(1
M`0,1`?_=``0`"O_$`3\```$%`0$!`0$!``````````,``0($!08'"`D*"P$`
M`04!`0$!`0$``````````0`"`P0%!@<("0H+$``!!`$#`@0"!0<&"`4###,!
M``(1`P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3\.'Q8W,U
M%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2EM<75Y?56
M9G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1``("`0($!`,$!08'!P8%-0$``A$#
M(3$2!$%187$B$P4R@9$4H;%"(\%2T?`S)&+A<H*20U,58W,T\24&%J*R@P<F
M-<+21)-4HQ=D154V=&7B\K.$P]-UX_-&E*2%M)7$U.3TI;7%U>7U5F9VAI:F
MML;6YO8G-T=79W>'EZ>WQ__:``P#`0`"$0,1`#\`]-L)WG7_`%A1+MH+G.AH
M$DDP``I6#WG_`%[(=H:ZI[;!^C+2'R8]I'N]R2D#^J83)_33`)D!Q;I_+`0?
MMUE]>ZJT;#^<SC_.4/LG36S%K>#HY[3^+BBU,:U@%<%GB'-(_*G:,?KZT/[J
M`FXF2]Q\]Q_O4=]G[SOO*LEK3S'WC^]1-;?$#XEO]Z5HX2A;;:W5MCA_:*-5
ME7E[6D[@2!/!U^"AL`/YOQW-_P#))4.<^YC=CF^X>YVT#0_UTD`D$;M_:_Q(
M^:))\2E!_P!82@_ZD)K,J3XE*3XE*#_J0E!_U(24PEW<E"N)-<$GD<$A%-AF
M&L<X_(#_`#G%`O.YA;;6/3)&N\#7MJB@D4U+W`$;':Z[B"?QU0][_P!]W^<?
M[T8X]#OH6[/)Y:1_G,<AOH>W\YCAXM>W^):C882);U]C`N<1!<XCP)/]Z&:6
MD@[K!!!(:]T'RC<C,J<\P2UH\2YO_DD=N+1^?:#\'-'\4;I7`9=/M9XV739>
M<:K<QX:7;"($:<.!\U=&X#4D_-4\;'PJ\HV5.#\@MB-X)#=)BL*[!_UA--=&
M6/%7JK?IV?_9_^T-'E!H;W1O<VAO<"`S+C``.$))300E```````0````````
M`````````````#A"24T$.@`````!%P```!`````!```````+<')I;G1/=71P
M=70````%`````%!S=%-B;V]L`0````!);G1E96YU;0````!);G1E`````$-L
M<FT````/<')I;G13:7AT965N0FET8F]O;``````+<')I;G1E<DYA;65415A4
M````&@!<`%P`4P!.`$<`1@!"`%4`+0!-`%<`4P`M`$8`4``Q`#``7`!B`',`
M:0!?`'``<@`S```````/<')I;G10<F]O9E-E='5P3V)J8P````P`4`!R`&\`
M;P!F`"``4P!E`'0`=0!P```````*<')O;V93971U<`````$`````0FQT;F5N
M=6T````,8G5I;'1I;E!R;V]F````"7!R;V]F0TU92P`X0DE-!#L``````BT`
M```0`````0``````$G!R:6YT3W5T<'5T3W!T:6]N<P```!<`````0W!T;F)O
M;VP``````$-L8G)B;V]L``````!29W--8F]O;```````0W)N0V)O;VP`````
M`$-N=$-B;V]L``````!,8FQS8F]O;```````3F=T=F)O;VP``````$5M;$1B
M;V]L``````!);G1R8F]O;```````0F-K9T]B:F,````!````````4D="0P``
M``,`````4F0@(&1O=6)`;^````````````!'<FX@9&]U8D!OX```````````
M`$)L("!D;W5B0&_@````````````0G)D5%5N=$8C4FQT````````````````
M0FQD(%5N=$8C4FQT````````````````4G-L=%5N=$8C4'AL0%(`````````
M```*=F5C=&]R1&%T86)O;VP!`````%!G4'-E;G5M`````%!G4',`````4&=0
M0P````!,969T56YT1B-2;'0```````````````!4;W`@56YT1B-2;'0`````
M``````````!38VP@56YT1B-0<F-`60```````````!!C<F]P5VAE;E!R:6YT
M:6YG8F]O;``````.8W)O<%)E8W1";W1T;VUL;VYG``````````QC<F]P4F5C
M=$QE9G1L;VYG``````````UC<F]P4F5C=%)I9VAT;&]N9P`````````+8W)O
M<%)E8W14;W!L;VYG```````X0DE-`^T``````!``2`````$``@!(`````0`"
M.$))300F```````.`````````````#^````X0DE-!`T```````0```!X.$))
M3009```````$````'CA"24T#\P``````"0```````````0`X0DE-)Q``````
M``H``0`````````".$))30/U``````!(`"]F9@`!`&QF9@`&```````!`"]F
M9@`!`*&9F@`&```````!`#(````!`%H````&```````!`#4````!`"T````&
M```````!.$))30/X``````!P``#_____________________________`^@`
M````_____________________________P/H`````/__________________
M__________\#Z`````#_____________________________`^@``#A"24T$
M`````````@`!.$))300"```````$`````#A"24T$,````````@$!.$))300M
M```````&``$````".$))300(```````0`````0```D````)``````#A"24T$
M'@``````!``````X0DE-!!H``````TD````&``````````````!"```"RP``
M``H`50!N`'0`:0!T`&P`90!D`"T`,0````$`````````````````````````
M`0`````````````"RP```$(``````````````````````0``````````````
M```````````0`````0```````&YU;&P````"````!F)O=6YD<T]B:F,````!
M````````4F-T,0````0`````5&]P(&QO;F<``````````$QE9G1L;VYG````
M``````!"=&]M;&]N9P```$(`````4F=H=&QO;F<```++````!G-L:6-E<U9L
M3',````!3V)J8P````$```````5S;&EC90```!(````'<VQI8V5)1&QO;F<`
M````````!V=R;W5P241L;VYG``````````9O<FEG:6YE;G5M````#$53;&EC
M94]R:6=I;@````UA=71O1V5N97)A=&5D`````%1Y<&5E;G5M````"D53;&EC
M951Y<&4`````26UG(`````9B;W5N9'-/8FIC`````0```````%)C=#$````$
M`````%1O<"!L;VYG``````````!,969T;&]N9P``````````0G1O;6QO;F<`
M``!"`````%)G:'1L;VYG```"RP````-U<FQ415A4`````0```````&YU;&Q4
M15A4`````0```````$US9V5415A4`````0``````!F%L=%1A9U1%6%0````!
M```````.8V5L;%1E>'1)<TA434QB;V]L`0````AC96QL5&5X=%1%6%0````!
M```````):&]R>D%L:6=N96YU;0````]%4VQI8V5(;W)Z06QI9VX````'9&5F
M875L=`````EV97)T06QI9VYE;G5M````#T53;&EC959E<G1!;&EG;@````=D
M969A=6QT````"V)G0V]L;W)4>7!E96YU;0```!%%4VQI8V5"1T-O;&]R5'EP
M90````!.;VYE````"71O<$]U='-E=&QO;F<`````````"FQE9G1/=71S971L
M;VYG``````````QB;W1T;VU/=71S971L;VYG``````````MR:6=H=$]U='-E
M=&QO;F<``````#A"24T$*```````#`````(_\````````#A"24T$%```````
M!`````(X0DE-!`P``````]<````!````H`````\```'@```<(````[L`&``!
M_]C_[0`,061O8F5?0TT``?_N``Y!9&]B90!D@`````'_VP"$``P("`@)"`P)
M"0P1"PH+$14/#`P/%1@3$Q43$Q@1#`P,#`P,$0P,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P!#0L+#0X-$`X.$!0.#@X4%`X.#@X4$0P,#`P,$1$,#`P,
M#`P1#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#/_``!$(``\`H`,!(@`"
M$0$#$0'_W0`$``K_Q`$_```!!0$!`0$!`0`````````#``$"!`4&!P@)"@L!
M``$%`0$!`0$!``````````$``@,$!08'"`D*"Q```00!`P($`@4'!@@%`PPS
M`0`"$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B,S1R@M%#!R624_#A\6-S
M-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8GE*2%M)7$U.3TI;7%U>7U
M5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0`"`@$"!`0#!`4&!P<&!34!``(1
M`R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"DD-3%6-S-/$E!A:BLH,'
M)C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25Q-3D]*6UQ=7E]59F=H:6
MIK;&UN;V)S='5V=WAY>GM\?_V@`,`P$``A$#$0`_`/3;"=YU_P!842[:"YSH
M:!)),``*5@]Y_P!>R':&NJ>VP?HRTA\F/:1[O<DI`_JF$R?TTP"9`<6Z?RP$
M'[=9?7NJM&P_G,X_SE#[)TULQ:W@Z.>T_BXHM3&M8!7!9XAS2/RIVC'Z^M#^
MZ@)N)DO<?/<?[U'?9^\[[RK):T\Q]X_O436WQ`^);_>E:.$H6VVMU;8X?VBC
M595Y>UI.X$@3P=?@H;`#^;\=S?\`R25#G/N8W8YON'N=M`T/]=)`)!&[?VO\
M2/FB2?$I0?\`6$H/^I":S*D^)2D^)2@_ZD)0?]2$E,)=W)0KB37!)Y'!(138
M9AK'./R`_P`YQ0+SN86VUCTR1KO`U[:HH)%-2]P!&QVNNX@G\=4/>_\`?=_G
M'^]&./0[Z%NSR>6D?YS'(;Z'M_.8X>+7M_B6HV&$B6]?8P+G$07.(\"3_>AF
MEI(.ZP002&O=!\HW(S*G/,$M:/$N;_Y)';BT?GV@_!S1_%&Z5P&73[6>-ETV
M7G&JW,>&EVPB!&G#@?-71N`U)/S5/&Q\*O*-E3@_(+8C>"0W28K"NP?]8337
M1ECQ5ZJWZ=G_V0`X0DE-!"$``````%4````!`0````\`00!D`&\`8@!E`"``
M4`!H`&\`=`!O`',`:`!O`'`````3`$$`9`!O`&(`90`@`%``:`!O`'0`;P!S
M`&@`;P!P`"``0P!3`#8````!`#A"24T$!@``````!P`(``$``0$`_^$-UFAT
M='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"\`/#]X<&%C:V5T(&)E9VEN/2+O
MN[\B(&ED/2)7-4TP37!#96AI2'IR95-Z3E1C>FMC.60B/SX@/'@Z>&UP;65T
M82!X;6QN<SIX/2)A9&]B93IN<SIM971A+R(@>#IX;7!T:STB061O8F4@6$U0
M($-O<F4@-2XS+6,P,3$@-C8N,30U-C8Q+"`R,#$R+S`R+S`V+3$T.C4V.C(W
M("`@("`@("`B/B`\<F1F.E)$1B!X;6QN<SIR9&8](FAT='`Z+R]W=W<N=S,N
M;W)G+S$Y.3DO,#(O,C(M<F1F+7-Y;G1A>"UN<R,B/B`\<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB(B!X;6QN<SIX;7`](FAT='`Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"\B('AM;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C`O;6TO(B!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87`O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(B!X;6QN<SID8STB:'1T
M<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\B('AM;&YS.G!H;W1O<VAO
M<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]P:&]T;W-H;W`O,2XP+R(@>&UP.D-R
M96%T;W)4;V]L/2)!9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@>&UP
M.D-R96%T941A=&4](C(P,34M,#,M,#14,30Z,3(Z,C$K,#@Z,#`B('AM<#I-
M971A9&%T841A=&4](C(P,34M,#,M,#14,30Z,3(Z,C$K,#@Z,#`B('AM<#I-
M;V1I9GE$871E/2(R,#$U+3`S+3`T5#$T.C$R.C(Q*S`X.C`P(B!X;7!-33I)
M;G-T86YC94E$/2)X;7`N:6ED.C,Y,D(X.#5!,S5#,D4T,3$Y,#=&0S!&044Y
M-S$P1C="(B!X;7!-33I$;V-U;65N=$E$/2)X;7`N9&ED.C,X,D(X.#5!,S5#
M,D4T,3$Y,#=&0S!&044Y-S$P1C="(B!X;7!-33I/<FEG:6YA;$1O8W5M96YT
M240](GAM<"YD:60Z,S@R0C@X-4$S-4,R130Q,3DP-T9#,$9!13DW,3!&-T(B
M(&1C.F9O<FUA=#TB:6UA9V4O:G!E9R(@<&AO=&]S:&]P.D-O;&]R36]D93TB
M,R(@<&AO=&]S:&]P.DE#0U!R;V9I;&4](G-21T(@245#-C$Y-C8M,BXQ(CX@
M/'AM<$U-.DAI<W1O<GD^(#QR9&8Z4V5Q/B`\<F1F.FQI('-T179T.F%C=&EO
M;CTB8W)E871E9"(@<W1%=G0Z:6YS=&%N8V5)1#TB>&UP+FEI9#HS.#)".#@U
M03,U0S)%-#$Q.3`W1D,P1D%%.3<Q,$8W0B(@<W1%=G0Z=VAE;CTB,C`Q-2TP
M,RTP-%0Q-#HQ,CHR,2LP.#HP,"(@<W1%=G0Z<V]F='=A<F5!9V5N=#TB061O
M8F4@4&AO=&]S:&]P($-3-B`H5VEN9&]W<RDB+SX@/')D9CIL:2!S=$5V=#IA
M8W1I;VX](G-A=F5D(B!S=$5V=#II;G-T86YC94E$/2)X;7`N:6ED.C,Y,D(X
M.#5!,S5#,D4T,3$Y,#=&0S!&044Y-S$P1C="(B!S=$5V=#IW:&5N/2(R,#$U
M+3`S+3`T5#$T.C$R.C(Q*S`X.C`P(B!S=$5V=#IS;V9T=V%R94%G96YT/2)!
M9&]B92!0:&]T;W-H;W`@0U,V("A7:6YD;W=S*2(@<W1%=G0Z8VAA;F=E9#TB
M+R(O/B`\+W)D9CI397$^(#PO>&UP34TZ2&ES=&]R>3X@/"]R9&8Z1&5S8W)I
M<'1I;VX^(#PO<F1F.E)$1CX@/"]X.GAM<&UE=&$^("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@
M("`@("`@("`@/#]X<&%C:V5T(&5N9#TB=R(_/O_B#%A)0T-?4%)/1DE,10`!
M`0``#$A,:6YO`A```&UN=')21T(@6%E:(`?.``(`"0`&`#$``&%C<W!-4T94
M`````$E%0R!S4D="```````````````!``#VU@`!`````-,M2%`@(```````
M````````````````````````````````````````````````````````$6-P
M<G0```%0````,V1E<V,```&$````;'=T<'0```'P````%&)K<'0```($````
M%')865H```(8````%&=865H```(L````%&)865H```)`````%&1M;F0```)4
M````<&1M9&0```+$````B'9U960```-,````AG9I97<```/4````)&QU;6D`
M``/X````%&UE87,```0,````)'1E8V@```0P````#')44D,```0\```(#&=4
M4D,```0\```(#&)44D,```0\```(#'1E>'0`````0V]P>7)I9VAT("AC*2`Q
M.3DX($AE=VQE='0M4&%C:V%R9"!#;VUP86YY``!D97-C`````````!)S4D="
M($E%0S8Q.38V+3(N,0``````````````$G-21T(@245#-C$Y-C8M,BXQ````
M````````````````````````````````````````````````````````````
M``!865H@````````\U$``0````$6S%A96B``````````````````````6%E:
M(````````&^B```X]0```Y!865H@````````8ID``+>%```8VEA96B``````
M```DH```#X0``+;/9&5S8P`````````6245#(&AT='`Z+R]W=W<N:65C+F-H
M```````````````6245#(&AT='`Z+R]W=W<N:65C+F-H````````````````
M`````````````````````````````````````````````&1E<V,`````````
M+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R('-P86-E("T@<U)'
M0@``````````````+DE%0R`V,3DV-BTR+C$@1&5F875L="!21T(@8V]L;W5R
M('-P86-E("T@<U)'0@````````````````````````````!D97-C````````
M`"Q2969E<F5N8V4@5FEE=VEN9R!#;VYD:71I;VX@:6X@245#-C$Y-C8M,BXQ
M```````````````L4F5F97)E;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%
M0S8Q.38V+3(N,0``````````````````````````````````=FEE=P``````
M$Z3^`!1?+@`0SQ0``^W,``03"P`#7)X````!6%E:(```````3`E6`%````!7
M'^=M96%S``````````$````````````````````````"CP````)S:6<@````
M`$-25"!C=7)V````````!``````%``H`#P`4`!D`'@`C`"@`+0`R`#<`.P!`
M`$4`2@!/`%0`60!>`&,`:`!M`'(`=P!\`($`A@"+`)``E0":`)\`I`"I`*X`
ML@"W`+P`P0#&`,L`T`#5`-L`X`#E`.L`\`#V`/L!`0$'`0T!$P$9`1\!)0$K
M`3(!.`$^`44!3`%2`5D!8`%G`6X!=0%\`8,!BP&2`9H!H0&I`;$!N0'!`<D!
MT0'9`>$!Z0'R`?H"`P(,`A0"'0(F`B\".`)!`DL"5`)=`F<"<0)Z`H0"C@*8
M`J("K`*V`L$"RP+5`N`"ZP+U`P`#"P,6`R$#+0,X`T,#3P-:`V8#<@-^`XH#
ME@.B`ZX#N@/'`],#X`/L`_D$!@03!"`$+00[!$@$501C!'$$?@2,!)H$J`2V
M!,0$TP3A!/`$_@4-!1P%*P4Z!4D%6`5G!7<%A@66!:8%M07%!=4%Y07V!@8&
M%@8G!C<&2`99!FH&>P:,!IT&KP;`!M$&XP;U!P<'&0<K!ST'3P=A!W0'A@>9
M!ZP'OP?2!^4'^`@+"!\(,@A&"%H(;@B"")8(J@B^"-((YPC["1`))0DZ"4\)
M9`EY"8\)I`FZ"<\)Y0G["A$*)PH]"E0*:@J!"I@*K@K%"MP*\PL+"R(+.0M1
M"VD+@`N8"[`+R`OA"_D,$@PJ#$,,7`QU#(X,IPS`#-D,\PT-#28-0`U:#70-
MC@VI#<,-W@WX#A,.+@Y)#F0.?PZ;#K8.T@[N#PD/)0]!#UX/>@^6#[,/SP_L
M$`D0)A!#$&$0?A";$+D0UQ#U$1,1,1%/$6T1C!&J$<D1Z!('$B8211)D$H02
MHQ+#$N,3`Q,C$T,38Q.#$Z03Q1/E%`84)Q1)%&H4BQ2M%,X4\!42%3055A5X
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M-C<V<C:N-NDW)#=@-YPWUS@4.%`XC#C(.04Y0CE_.;PY^3HV.G0ZLCKO.RT[
M:SNJ.^@\)SQE/*0\XSTB/6$]H3W@/B`^8#Z@/N`_(3]A/Z(_XD`C0&1`ID#G
M02E!:D&L0>Y",$)R0K5"]T,Z0WU#P$0#1$=$BD3.11)%546:1=Y&(D9G1JM&
M\$<U1WM'P$@%2$M(D4C721U)8TFI2?!*-TI]2L1+#$M32YI+XDPJ3'),NDT"
M34I-DTW<3B5.;DZW3P!/24^33]U0)U!Q4+M1!E%049M1YE(Q4GQ2QU,34U]3
MJE/V5$)4CU3;52A5=57"5@]67%:I5O=71%>25^!8+UA]6,M9&EEI6;A:!UI6
M6J9:]5M%6Y5;Y5PU7(9<UETG77A=R5X:7FQ>O5\/7V%?LV`%8%=@JF#\84]A
MHF'U8DEBG&+P8T-CEV/K9$!DE&3I93UEDF7G9CUFDF;H9SUGDV?I:#]HEFCL
M:4-IFFGQ:DAJGVKW:T]KIVO_;%=LKVT(;6!MN6X2;FMNQ&\>;WAOT7`K<(9P
MX'$Z<95Q\')+<J9S`7-=<[AT%'1P=,QU*'6%=>%V/G:;=OAW5G>S>!%X;GC,
M>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^`7YB?L)_(W^$?^6`1X"H@0J!
M:X'-@C""DH+T@U>#NH0=A("$XX5'A:N&#H9RAM>'.X>?B`2(:8C.B3.)F8G^
MBF2*RHLPBY:+_(QCC,J-,8V8C?^.9H[.CS:/GI`&D&Z0UI$_D:B2$9)ZDN.3
M39.VE""4BI3TE5^5R98TEI^7"I=UE^"83)BXF229D)G\FFB:U9M"FZ^<')R)
MG/>=9)W2GD">KI\=GXN?^J!IH-BA1Z&VHB:BEJ,&HW:CYJ16I,>E.*6IIAJF
MBZ;]IVZGX*A2J,2I-ZFIJARJCZL"JW6KZ:Q<K-"M1*VXKBVNH:\6KXNP`+!U
ML.JQ8+'6LDNRPK,XLZZT);2<M1.UBK8!MGFV\+=HM^"X6;C1N4JYPKH[NK6[
M+KNGO"&\F[T5O8^^"KZ$OO^_>K_UP'#`[,%GP>/"7\+;PUC#U,11Q,[%2\7(
MQD;&P\=!Q[_(/<B\R3K)N<HXRK?+-LNVS#7,M<TUS;7.-LZVSS?/N-`YT+K1
M/-&^TC_2P=-$T\;42=3+U4[5T=95UMC77-?@V&38Z-ELV?':=MK[VX#<!=R*
MW1#=EMX<WJ+?*=^OX#;@O>%$X<SB4^+;XV/CZ^1SY/SEA.8-YI;G'^>IZ#+H
MO.E&Z=#J6^KEZW#K^^R&[1'MG.XH[K3O0._,\%CPY?%R\?_RC/,9\Z?T-/3"
M]5#UWO9M]OOWBO@9^*CY./G'^E?ZY_MW_`?\F/TI_;K^2_[<_VW____N``Y!
M9&]B90!D0`````'_VP"$``$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!
M`0$!`0$!`0$!`0$!`0$"`@("`@("`@("`@,#`P,#`P,#`P,!`0$!`0$!`0$!
M`0("`0("`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#
M`P,#`P,#`P,#`__``!$(`$("RP,!$0`"$0$#$0'_W0`$`%K_Q`#<``$``00#
M`0$`````````````!0,$!@<!`@@*"0$!``(#`0$!``````````````0%`0(#
M!@<($``!`P("`P<)%04$"`8#```!``(#!`41!B$Q$D%189&2$P=QT2(RTQ14
M%96!H;%28H*R,U.3-'24-=46-E:6%PA"(T/457(E176BPM)C<[,D-^&#M7:&
MUE>7&!$``@$"`@4&"0@(!`8#``````$"`P01!2$Q49$206&AT3(&<8&QP4*2
M$Q05(M(S4Y,T5%7A4F)R0W,U!_#Q@A:RPB.STY2#1'3_V@`,`P$``A$#$0`_
M`/OINDLD%NK9H7F.6.FE?&\`$M<UI(<`X%I(.^$!K7Q]>/#Y>1!W)`/'UX\/
MEY$'<D`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<D`\?7CP^7D0=R0#Q]
M>/#Y>1!W)`/'UX\/EY$'<D`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<D
M`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<D`%^O)T"OE)W@R#N2`B;YFN
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MFO:2"8J^VVM[=&XUU/1T[F`^:M96E"7HX>`Z4L\S.D\?;*:V2BO-@9O;_P!2
MN8SLMN\54TZ-J>UOHG-X3WO4TN('`'*/*P?H5=_Z"UH]YD]%S:8<\'YGUF<V
M_ISI[B6M9FZ:CE=A^ZN-+3TAQ/[/..IGPGE*-*VKQTN&*YBVHYUEM;0KCA>R
M2:Z=729C!G7,-4P24M^=4QD8A]/WA.W#?QB@<%Q::T-8,LXRC47%3DI1YFGY
M"I];\SC7>*CWFD_EE@R/KAF;^L5'O5'_`"R`?7#,W]8J/>J/^60#ZX9F_K%1
M[U1_RR`?7#,W]8J/>J/^60#ZX9F_K%1[U1_RR`?7#,W]8J/>J/\`ED`^N&9O
MZQ4>]4?\L@,EMN8[Y-2,DEN4SWESP7&.G!P#R!VL(&@("^\?7CP^7D0=R0#Q
M]>/#Y>1!W)`/'UX\/EY$'<D`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<
MD`\?7CP^7D0=R0#Q]>/#Y>1!W)`/'UX\/EY$'<D`\?7CP^7D0=R0#Q]>/#Y>
M1!W)`/'UX\/EY$'<D!;SYGNM/AM5T[B['`!D`U;I)BWT!'.S??CH96N8/^%`
MX\9A&E`4/K3F'^JS^]4O\N@'UIS#_59_>J3^70#ZTYA_JL_O5)_+H!]:<P_U
M6?WJD_ET`^M.8?ZK/[U2?RZ`Y;FG,)<T&ZSX$C^%2[_Q=#*UH\L7/IBZ3X+E
M<88\YW&.&&OK8HF"CLN#(XZJ5D;`76MQ(:QH&DXJXA;T7"+]FL<%MZSY[7S;
M,HW-Q"-Y)0C-X:(ZL7S%K%TQ=*\S@V'.%VF<=R.@LS_8VDK+M[=:Z<5OZS2.
M:YK-X0O)M\T8O_E+:OS+TY7K&2DZ5,XY;D?VKX*?)\M,P_$JS+51(6C>V\5M
M!V=/1*VA-<_%Y4SA7I=XKSY5'.[JWD^5>R:]65-OI,2K+C^I:T05%QK?U&YA
MN=!3#G):>@RQDV@K&0X@%[I:C+TT;RTG3L`'=7=5,NFXQAEL8R>V4FO*5=6Q
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MI>^_ET^0V'Z(6/=+;ZE=/6/C^<_F$]T/FD/<NEWICN`)@Z5\VVF7#L74%)E-
M\0/#3U>6YP[A[);PM[6.NVA)<_%YF1;C-,[KKY&>7%*6V*I8;I4WY3`+ETE?
MJHAVGV?IZN-<T:H;C8,IT4YW@)H<N2PD]4!2H4LK?TE@EX')^<HKB\[]1Q=I
MWLE-;)4Z47O5-HP"Y]/?ZQ;3M&JZ0,T2Q-QQGH+/DZOAP&[M4^7'/`PWVA28
M6>2SU48)\[DO.4=SWA_N/:XNIF5=QVQA1DNBGCT&'O\`U<_J6B>8Y>EN_P`4
MC3@Z.6RY2B>#JP+),M-<#BI'PG+7JM([Y?.*I]_>^46XRSZLI;'"DO+3'_\`
M77ZE?_R[??(^4/\`ZVGPG+?PD=\NLQ_OWOE^?U?4I?\`C!_5W^I4`D]+M]P`
MQ/\`<^4-0_\`C:?"<M_"1WRZQ_O[OE^?U?4I?^,]%9*OGZVLXVVW7J7IF^K5
MGNE-#6T=1<Z#*M97344[0^&=MNH<LDQ\[&0YHDD:<#I`53<SR.WE.FK)SJ1>
M#P<DL5KTN1]`R>T_NCF]O;WDN\D;>TJQ4HN:I2DXO4^"-/1BM*Q9Z"R]2=+U
M#S<N:/U#=(.8YVX%]/;K-D:P6\G''9#FY8JJQ[>JX'!5=6YMI-JCEU*$>=RD
M_P#BP/>6&1YS1X99EWQO;B>R$*%*/_;E+I-KQ9YSC%&R,9CN$H8T-$D\5MDF
M?A^U*]MOC:]YW2&M'`H3C%MOA1ZB$JD(QC[63P6MX-^-X+%^(G;7G7-<T<QF
MO=3(6R-#2Z"A&`V<<!LT@W5RFDG@D2:,I2C)R>+Q)49OS,TX^-I3P.@HRWB%
M."M#L7D>=[X-$U2]W#&V!A/F&`A`25-FZXU+MAE?4-?@3LOB@U#7@YL9:<!U
M$!>^/KQX?+R(.Y(!X^O'A\O(@[D@'CZ\>'R\B#N2`__0^^6]?--Q^*3>P*`U
M$@"`(`@"`(`@"`(`@"`Y`)(`&).H(##;OG[*MEEDIZFY"IJHB1)2V^,UDC'#
M06/?&1`QX.X7KO"VK5%BH8+GT%9<YQE]K)PG7XJBY(KB_1TF`W#IE:-IMHL1
M=Z6>YU.R.`][TH)PX"]28V'Z]3<5%7O,M*M[3QR?F768+<>DC.5R#F^-&VZ)
MVCFK73QTN`WN?(?.3PXJ1&UH0U1Q?/I*JMG>9U\5[QP1?)!8=.LUOF"HJ*NE
M=)65-15R&6,F2KGDJ'%Q)TXRN=@>HI"2BL(I)<Q5SG.H^*I.4I<[;\IAZ&H0
M!`$`0!`$`0!`$`0!`$`0%:FJJJB>):*JJ:*0:0^DGEIW8\/-N:#YJPTI:))/
MPF].=2D^*E4E&7,VO(9M;NDO.-OV6NN,=RB;@.:N=/'.<-X3L$<PXRH\K2A+
MT<'S%I1SS,Z."==3CLDL>G69S;^F2%VRV[6.2,Z-J:VU#9&<)YBIV7^8'J/*
MQ?H5-Y:T>\T7@KBT:>V+\SZS/[/GG*][ECIZ2YLBJY2!'25S'4<TCC^Q&9?W
M4C\=P..*C3MZT$W*&CFTEQ;9M874HPIUTJCU*7R7XL='29<002"""-!!T$'>
M(7$L3A`$`0!`9=:?@,?]J3_F.0$D@"`(`@"`(`@"`(`@"`(")N7;Q?V7>B$!
M&H`@"`(`@*9E8-W'@&G_`,$!T$_9#9;NC7U=Y`M#Q-`SV*U,KZV=U(V:66MJ
MY7.G<Z4;3ZB1YV6'!H&)T:%9JI/ABN+1@CQT[*V5Q7DZ6,N-O3IUMEXQC(QL
MQ,9$WTL;&L;Q-`"U\)WC&,%A"*2YM!V63)!YF^SE[^(2>S8MZ7TM+PD+,ON-
MW_+?E1Y_&H=0>@K4\(<H`@"`(`@"`(`@"`(`"0<02#OC0>-#/@+&NM5JNC#'
M<[9;[@T@C_JZ2&9VG>E+>='F.68RG#3";3YF<*]M;7*X;FVIU%^U%/IUFOKE
MT0Y,KMIU+!76:5VD.M]4Y\`=O][57.LV>`$*5"^N(ZY*2YUU%'<=U<HKXNG"
M=&7[+T;I8FOKKT(W2)DKK1>J.N;LNV(:Z&2BF.@X#G8^>@Q\P*5#,8-KVE-K
MP:2AN>YUS%2=I>0FL-4EPO>L5Y#]+\@T%5;\AY,HJF+9J*3*]DIYPPB1@EBH
M(6/#7MQ#FAPT'=7D+J:G=7,HZG-^4_1>14*MODN4TJJ^7&VIIX:=*BDS*EP+
M4(#(+-[5/_Q&^P7&IVB5;]F7A\Q,K0[A`2-K^%M_L/\`00&3H`@"`__1^^6]
M?--Q^*3>P*`U$@"`(`@"`(`@"`(`@._-O#=LL?L>FV7;/*PP0S@\,<'@8QG&
M:6#*68YH)'PS1VF<QRQ.+)(RYT<;BQ[<"UQ8\C$;ZZT$G7I)K1Q$#,Y2CEU[
M*,L)*F]*\1X_C`#&@:!L@^:1B2=\DJ[/G"6"P6H[H`@*,\+*B,Q2C%CM8W01
MI:X'<+2@(&:R2@DP2M>-QLG8NY0Q:?.0$=+0UD/;P/PT]DP;;<!CNMQWD!:'
M02#H(UC=0!`$`0!`$`0!`$`0!`$`0!`$!P0",#P'>((U$$:0X'41I"!I/6>P
M\J3SU65\OU%3*^>>:U4KI9I';4DC@TMVGN.ESMEHTZRJ.JDJM1)8+B9])RZ<
MJF7V4YR;FZ:Q;ULGUS)@UZ`"3O`$GB&E`7<5!638%E.\-)'9R?NVX;^+\#AY
MB`DH;)(2#/*UH_:9'V3NIMG!HQZA0$_%$R&-L48V6,&`'HDG=)*`J(`@"`(`
M@"`(`@"`(`@"`B;EV\7]EWHA`1J`(`@"`L7N+B<3C@3AP:=Q`=4!R-8ZH]%`
M:?J_A53\9J/^<]6"U+P+R'F*GT]?]Y^4MUL:A`0>9OLY>_B$GLV+>E]+2\)"
MS+[C=_RWY4>?QJ'4'H*U/"'*`(`@"`(`@"`(`@"`(`@"`X(Q!&_H0&Z,O=+$
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M#`+0[E[%;*N328Q$-&F1V!P(.G9&T4!+4=N[VDYUTFV\`@!HP:,>$DD^<@)-
M`$`0'__2^^6]?--Q^*3>P*`U$@"`(`@"`(`@->YLZ6>C;(TTE+FC-]LM]QC:
MUS[1`)KC=V[;0Y@DH:*.5\+I&G$"0M.'`I%*TN:ZXJ5%N.W4M[*7,>\>193*
M5/,,SIPK+7!8RGZL<</'@:"S#^L7*-+MQ94RE?KZ\8AE9=YH+%1$[CA`.^ZY
M[-WM6E6%/)JKP=6M&/,M+\R/'WG]S<MIMQR_+:U9_K3:IQW:9=!H[,'ZJNE2
M\<XRUR67*L#\0UMJH!5U;`<1HK[D9W;7"UC5.IY59P[2E-\[T;D>3O?[A=X;
MGB5O*E;P_8CC+UI8Z?$C5C>E?I097>,F](.;>_=K;YTW>H<S'>-,3WJ6>IV,
M%*]TM>'A]WAP^`\\N\.?JM[?XS<^UV\;PW:O%@9K6_JGZ4;=E:^4MW=9,T4[
M[9)&\W*@%%6D<Y%B[OVVNAVGZ-;HW+E#*K25:FX*4)8\CQ6YEQ+^X&?T[*YI
M73I7%-PP^5'AER>E'#I1A%A_53E6I$<>9,M7NR/(#75-MD@O-&-`[(QCO:L:
MWUI4JIE558^SJQEX=!7VO?RPJ8*]LJM)[8X37F9NS+/25D/.4C8,MYGM]?6/
M8YXMLG.T5SV8QC(10U<<4K^;&EVQM8#3J4*K:W%'34I-+;K6\]/99WE.8M1L
M[Z$ZGZNJ7JLSA1RS"`(!CAJ0%&6"";VV*-^YBYHQX\,4!'RV>EDQV-N$G=8=
MH#UKL?10%A+9)Q[3+'(-.AX,;MW#3V3<4!'2T-7#CMP28>F:-II&_BW'1U4!
M:ZC@=!WMU`$`0!`$`0!`$`0!``"3@`2=X:3Q!`7<=!62]K3O`(Q#GX,;AACC
MBXC`(#V9D>R3.RCEHS31Q_W32Z(P9#AV6C$[+525UA6JIZ^(^CY7_3;'^6C-
M8K/21]N'S'##LW8#DLV5R)Q(1P0Q#".*-G"UC0>/#$H"J@"`(`@"`(`@"`(`
M@"`(`@"`("RJZ9TY:6.:"T$8.T`XG?W$!&/I:AG;1.(&ZW!XT88]KB=U`6Y!
M&L$=5`$`0%@=9ZI]%`<(#D:QU1Z*`T_5_"JGXS4?\YZL%J7@7D/,5/IZ_P"\
M_*6^YCN#6=P=4K)KS\A%U=\LU!B*NYTD3AKC;()I?,CAYQV*WC3G+LP9&JWM
MG0Q]K<P3V8XO<L3!<PYUMU;;JRVVZ"IG-9%S#ZF=G,0QQES7.>QA)DD>0W`:
M`%)I6\E.,YO!+24E_G%O6H5:%O"4G)88O0EX.5ZC60T:%-/-A`$`0!`$`0!`
M$`0!`$`0!`$`0&I^F9K79.8UP#FF\T&(<`0>PJ=8.@J98?>/]+/,=[M.413U
M>VCY&>:;7<[K8IVU-CNMSLU0UP<V6UU]50N!!QU4\K&'S0K><(55PU(1DN=)
MGSRVN;FRFJEE<U*,URPDX^1H_53]%F:LR9VR?G:JS?>:S,53:<S6NAMU1<S'
M--34<UH?/)!MMC890^8;1+]IV.ZO'9[0HV]Q15"FHIP;>&W$_17]K,WS/-\L
MS2>9WLZ\Z=>,8N6EI.&.&/+IVGM-H#1@T!HWF@`>=@J,^HG*`(`@"`(#_]/[
MY;U\TW'XI-[`H#42`(`@"`(`@`0+6C\ENGAK1TR](Q#0"[,&D@#$_P!W4&LZ
MRO76/W*V_=\Y^<>]J7^Y\[?+[;_EB:F4D\\$!P2!K('5T(8QPUEA>K;<;E8;
MQ#;J"LKII*&1K(Z6GDF+G%\>#06MV03PD+>G.$*M-SDDL3%2A7N+>O&A0G.7
M#R)LUY:NAS/=Q#'3T=%983A^\NM6WG<,,3_TM+S\F(X2%*G?V\<<&Y/F7G9!
MM^ZV;U\'.G"E';-Z=RQ9Z"Z'>A6CL>?<M7>XWZ:X5M'45+XZ>BHV4M("^AJ8
MW-=-,Z2H>W!QU`:577N82G0JPA3PBURO%Z]Q[+NUW3I6N;65Q7O93J1D\%%)
M+3%K6\6>[FV2V-`;WN78;KY)"3U3M!47M:GZQ]95A:+^%CX6SI)8;<\=BR2(
M[\<KO0?M`HJTUK>)K++[66J+B^9]9&39:D&)IJMKAN,GC+3RV$CSENJZY8D6
M>5R_A5D_#UHBIK1<8,2ZE<]HT[<)$K<.$-[(<2Z*I!^EI(D[.YIZZ3:YM)'.
M!8[9>',=Z5S2T\1`6^O417HUZ`@"`X0%&2F@E!$D,;\=]HQY6L("PEL]))CL
M<Y"[<V7;31ZUV/HH"/ELE0T_NI8I1O.QC=P:3B,4!'R457%I?!(`-;FC;:,/
M5-Q"`M<,-!T%`$`UG`:3O;J`NXZ"KE[2!^&^\!C>#2XC%`2$=CF)!EFCC&\P
M%[CIU8G9`0$A%9Z2/`O#YCZMQ:WDLP]%`7\<$,0`CBC8!JV6@'CPQ*`JNU'J
M'T$!Z\R7]D,M?Y13?ZRI;G[Q6_>/H^5_TRQ_EHR9<2<$`0!`$`0!`$`0!`$`
M0!`$`0!`$`0!`='1L>,'L:[J@%`6SZ&!VH%A]2='$<0@+5]N</:Y`X:=#@6G
M@U8C!`0CX)6N(+"=)U$'=.\@.C8I':F.ZI&`XS@@*\=*]SFAQ#<7`;YUC>T(
M96EI'CG,&>;RVZW2EI(Z2DCI[C7P-D$;IYGB*KEC#RZ4[#2[9QPP."OJ5M!P
MA*3;;2\A\MO<ZNU<W,*4802J26UZ&URF$5=WNE>3WY<*N<']ATSFQC@$4>PP
M#S%)C3A'5%%/5NKFM]+7D_'HW+01P`&H#BT\:W(YR@"`(`@"`(`@"`(`@"`(
M`@"`(`@"`U1TR?8]G^<T'L*E3+#[Q_I9YGO=_28_SH>1GEM71\U/U"_0)]B.
MD?\`]X6?_P!"D7D>\?WFW_<?E/O_`/9O^E9W_P#JA_VV>\UYT^Q!`$`0!`$!
M_]3[Y;U\TW'XI-[`H#42`(`@"`(`@"`\'=,WZ=ND"_9VS-G++C[+>:"_5HN+
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MS<-LK&1B.)HIW!K(VMC;K;@`Q@:/.7-:9)\Y,J\,*$XQ22PU+08I0V.\W/#O
M"UUU2T_Q&0/;%YLL@9&!YJ[2J0AVI(@TK2ZK_0V\Y>+1O>@V7E#(M\MUXH;O
M<>]*6&D,C^]A-S]5(Y\+X@TB(&*,`OQ)+CJ46M7IS@X1Q;9>9;E5U0N:=Q6X
M8QCCHQQ;T8<F@W(HAZ0(`@"P"G)%%,-F6*.0;TC&N]$$K*;6IF)0A-83@FN=
M$7-8K;-CLQ/IW''LH)"T`G=V';35T56:>EXD2IE]K/2HN+YGYB*FRU*,33U3
M'C3@V=A8X[PVF;3?.6ZKKTH[B)/*Y+Z.LGX5ATD5-:;C!I?3.>-UT)$K?]`E
MWG+HJD'JD0YV=S33;I-KFTD>[%IP>"P[SP6GB=@MR,]#P:P80!`$!1DIX)?;
M(8W\+FC'C&!0%#Q=0X@][1Z-0[/#<]5P("O'!#%[7%&S#5LM`/'K0R5D,!`$
M`0'!U'J'T$!Z\R7]D,M?Y13?ZRI;G[Q6_>/H^5_TRQ_EHR9<2<$`0!`$`0!`
M$`0!`$`0!`$`0!`$`0!`$`0!`0+^W=_:=Z)0'5`<@D$$:P01U1I0:CS+G3H7
MO+[G6W7+$\%QI:^HFK)+=5S-I:ZDFJ)'2S1PS/P@JX#(XEF):]H.!Q5M;W]-
M0C"LFFEACK3ZCP6:]U;IUZMQE\E.G-N7"WA)-Z7@]36.K4T::NN6,R60D7:Q
M72B:-<LE)(^#JBHA$L)'KE/A6I5.Q4BWX3R]QE]_:-JYLZD%MP>&]8H@6O8[
MM7-)W@1B.J-8*ZD--/4SL@"`(`@"`(`@"`(`@"`(`@"`-[-P8P&1Y.`9&"]Y
M.\&L!.*>%A?*>$=+YC(*/*N8JX;4%IJ@PZ0^<-IFGJ<^YCCQ+C*XHPT.HL2?
M1RR_KZ86LL-KT>7`XK,JYBH6[=1::HLW7P-;4M'5YASRWS0L1N*,W@JBQ%;+
M+^@FYVLL-JT^3$TITL6^XW++,5#;;;<;E7/O=O:RBH*&JK*MQV:D8"GIXI)?
M.5C93A&LY2FE'A>EM(\=WIHUZ^6PHT*$YUO;Q^3&+E+4^1)LQ;*?Z5NG3-IA
M?%DN7+M%-LGQCFZJALD,<;L/WII'F6YR-:#CLMAQ*D5LXR^CBG7XI;(K'IU%
M/EW]O.]V9<#CE;H4GZ5:2II<^&F3]4_4+H&Z%J#H0R?46"*[R7Z]7JO9=\QW
M81.I:*6OCIA2P4MKHW%TD%!108M:YY,DKB7.PT`>2S&_EF%=5'#AIQ6$5RX;
M6]K/T!W/[JT>Z>63LXW+K7=6?'5GAA%RPP2A'DC%:%CI>MF[5`/5A`$`0!`$
M!__5^^6]?--Q^*3>P*`U$@"`(#ASFM&+G!HX2`@+=U7"W42X^I!XL3@$!;NK
MG?LQ@;VT2?.&"`MW5$SM;R.!O8^AI0%$DG222=\DD\9TH!B0",=!UM.EIX"T
MX@A!S<ACURRGEB[XFX6*WRO=KFBA%+4=42TW-.QZN*ZPK58=FH_*0J^76%SC
M[:T@WM2X7O6!B@Z)LH<_SI%V,6./>IKSS7]GG.;YXM]<NOOE?##1CX"O_P!N
M9;Q8XU>'9Q>?#$FJC*F6;1:+B;=8[?!(VD?A.^$5-1B"S3SU3SKL=&Y@M(UJ
MTZD>.JVL25/+[&VMJOL+2">&O#%[WB8%B2`"=`U#4!U`-`4LJ<7@CA`$`0!`
M$`0!`$`6`4Y(H9ALS112C>D8U_GD8K*;6ILQ*,)IJ<%)<Z(J:PVV4DMC?3N.
M[#(0T?\`EOVFKHJLURXD.>7VT]*BXOF?F(N;+<HQ-/4LDWFS,,9/!M,VF^<M
MU77I1(D\KDL73JIK8T14UJN$&)?3/<T:WPX2M\W9[(>:%T52#]+21*EI<T\6
MZ3:YM/D(_?!Q!&@@@@@[Q!T@K<C;5RA`$`0!``"=0)ZB&0A@X.H]0^@@/7F2
M_LAEK_**;_65+<_>*W[Q]'RO^F6/\M&3+B3@@"`(`@"`(`@"`(`@"`(`@"`(
M`@"`(`@.0USC@T%QWF@D\0TH->HL+G=;39873WFZVVTPM:7%]QK:>DT`8D[$
MLC9#HX%M"$ZCPIP<GS(XU[BVM8N=U<4Z</VI)?I->5F?<MPXOIZJ2X;?9QFB
MA<^*1KQM,<V>3FX]ES3B"NBMZKUK#PD*IF]C%)PJ.>*T<*T;V8Q4])4Y)%%:
M86MW'U=0][B.%D(8T<9756J]*;($\]G_``K9)<[Q\A;,Z2;H'`R6RWO;NACZ
MF-WF$O<%M[M#]9G..>7"[5"#7C)ZCZ1K7+@*ZDJZ)QUOC#:J('UA9*!ZTKG*
MVFNS),FTL[MY?2TY0>]=9EU#F&RW`;%'=:20O`Q@DE$+R2.U=!.&$G@P*XRI
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MF\+JSJ0YW%X;UBB$:]C^U<UV_@0<.KAJ70BIIZF=D`0!`$`0!`-;@T!SGN[5
MC&N>\]1K07%8&MI+2R?H<K9BN(:ZFM-4V-W\6I`I(AP[4Y82#P!<I7%&#PE4
M6.\GT<LO[CZ.VDH[7\E=)EU%T8W"3`W"XTU*-&,=,Q]3)PC;=S<0/*"C2OH+
ML0;99T>[M9X.O<1BMD5B]^A&6T'1WER`MYZ&LNDHPQ;/,[F]K_@4P8T@'<*C
MSO*\M":CX"THY#80PXH3JRYWHW(S^W99-,UK:"T4UO81H<(8J<X<+R#*3BHL
MZKEIG-MEW0RYTTE0M8PCX$OTF019=D=IJ*H#'6(FESNIMOP'G+DYKD1.C8-_
M25=WZ24ALENA()B=,\:G3/<[_1:6M6..6G22(6="&GA;?.3-(XTCR^D#:1Y;
M@9*9C(9"-&@R1M:]PZI*TUZV2HI0>,(I/F23WZR49<ZH'LW-ETXDR#LCHW7`
M@E`7D=TC.`DC<WA:0X8]30<$!>1U=-)VLS`?2N.P[S`[#%`7'"-(WP<1QC0@
M"`(`@"`__];[Y;U\TW'XI-[`H#4.(WQQA`,1OCC"`8C?'&$!!2R[;W%T@)Q(
M&+AH`T`#<&A`4]MGIF\H==`-MGIF\H==`-MGIF\H==`-MGIF\H==`-MGIF\H
M==`-MGIF\H==`-MGIF\H==`6]7%'5TM12ND#&U$+XBYI:2W:U.`)P.!`68OA
MDI+D-*D%4A*FW@FC6E7E^YTA=LPBKB&.$M*X/Q&YM1DB1APW,"ID:L)<N#*.
MI97%/'"'%':NHA7_`+H[,H,3AK;*#&[B?@5TT/4R,TUVDT^<Z<['[HSEMZZR
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M-=Z;W@CLAA'])*6/IISW2N9"VYT^8FC`<S74D=9.1J`[YI.;J`3ODE:5+&W:
MQ<>'P/`[VW>/,Z;4?;*LMDEB]ZTGJGH?O.8^E.\26.IL%/EV2&WR7*6Y2W!L
MM.:>&6**5L=`X=^F8\\"T8[.^0JB]A2LX*HJCDL<,,/.>X[N7%WG]R[1VT:,
ME#B<F\5@FD\(Z\=.CD/T!ME#!:;;06NG>Y\%OI8J6-\I;SDC8FX%[]G0'/<2
M<!J7FYR<YRF];9]>MZ,;:A1MX-N$(I+$OL1OCC"U.PQ&^.,(!B-\<80#$;XX
MP@&(WQQA`,1OCC"`8C?'&$`Q&^.,(!B-\<80#$;XXP@&(WQQA`,1OCC"`8C?
M'&$`Q&^.,(!B-\<80#$;XXP@&(WQQA`1UPO5DM$9FN]ZM%IB:W:+[E<J2C['
M?#)Y62.'4!Q6T83F\(0E)\R;.-:YM;9.5S=4Z<?VI)>5XFJ[S^H#HLM!?'!?
MGWZH;B.:L=.Z>(N&YWY4&"F`QW<2%-IY;>3TNGPKG?F//77?'(+;%0NW6GLI
MK%>L\$:GO/ZH9I`YF7LO4%*-.Q4WFX"JD&\324ABBQX#(5,IY0E]+5;\"ZSS
MEUW_`)/%65C"//.6+W1P726]DS'G_I(MLMRKND"ILMM[\GHO%V7:>GH'.,+6
M.>XU$1:X-<),!BYQ6M:-M9S5.-LI3PQQD\3IEU;.N\-M*ZK9S*E;\;CPTHJ.
MK#E7AT:R_INCC)\<G?%PAJ+_`%9TNJK[<)J]SG;YC?((AIX%RE?7#6$&H1V)
M8%A2[MY3"7'6HRKU=M23ET:C/GV.Q5$4>S3Q0AL;&-=2R\SLAC`T-`!+>QPP
MTA1U.:U/$N96-I.*2I):.308_<LM04E+4U=/7XMIHG3.BF#,2QN&($C"WLM.
MZ%TC4;:3CK(-QET:5.I5A5>$5C@^LPT30D8\['I]6WKKL5.*VCGH?=8^6WKH
M,5M.#)`[7)$>$O9B.H<<0@T,DJ._7"W$=XW>HIP-(8VJVHO>I'/9AP8+64(2
M[44SO2NKBCA[*O)+9CHW&64?23=8,&U?B^O:,,7.PII2,=)VX7;!)&^U<96T
M'V<46-+.[J."JQA-;GT&54?278IL&UL510N.M[71U4(/"8RV0#UJXRMIKLM,
MGT\\M9:*M.4'O1EM%F6PW!NQ1WJW3AV@P25,4;CB-3H*@MQXBN4J52/:@RRI
M7MI76%*Y@T^1O#H9$W;).2[[B^XY?M,DKA\*IHVT=3B?VQ/1NB+CNXZ5O"XK
MT^Q5>&S6B-<91E=WBZ]C3<GRI<+WK`UO=.@K+E1M.M%YN-K<>UBJ>:N-.W@)
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M05]14SNDEN$3*:J=`'-%/[?^^9%LZ6@`8JGNZT95<%4Q@ER=)[S(<MN(6:G.
MTX*TI-XR6#PY->G#8;-BL#G8&IK&`Z.QB[,]0O>0/.*A>T7(CT4;"3:=2KNT
M^4DHK-;(^V;SYUXS28CDMV6K7CEM)$+.WCKAQ/G)2-L$0V8FPQ`;D;6-\\:2
MM23%*/9BEX#OMM].WE#KH9&VSTS>4.N@&VSTS>4.N@.['-Q[9NK?'`@*NVST
MS>4.N@&VSTS>4.N@&VSTS>,==`2-LE_ZC8$G8EKB6[6@D#0<,<,0@,@Q&^.,
M(!B-\<80#$;XXP@&(WQQA`?_U_OV?VCNT[4]OVGKO4H"Q\GH!Y/0#R>@.AUG
MYKU[NOS>%`<>2T`\EH!Y+0#R6@'DM`/):`>2T`\EH#LW7_AOK=:PP4)^V'S-
MJ_C]MYG`MEXS2>OT?&4/P^L[S3U!^'TWCU!^'TWCU!^'TWCU!^'TWCU!^'TW
MCU!^'TWCU!^'TWCU!^'TWCU!^'TWCU!^'TWCU!^'TWCU"G+VH^S?;?Q>UU'5
MZI97+VC66K^'XRA^%%GUCG]B/PHGK#[$?A1/6'V)CU1[?+_VS]L=\(]OU_Q?
M]YOKK'4OI/$19]N?W37RZ_'SE'_]6K/VIK_Z9?47;._[=[GP+MO7+67_`,GC
M-Z>O_P"KXB;M_P`)D^RWM3OF_P"$]LWVS_=;_#@N<M7I>,DT/I']#J]'7_D3
M/D]<R8/)Z`>3T`\GH!Y/0#R>@'D]`/)Z`>3T`\GH!Y/0#R>@'D]`/)Z`>3T`
M\GH!Y/0#R>@,?O/MD?V/U#YY]LUGVO@76'+VO$0[KM+Z'_7K+,:A]@]6YJ\S
M@6?7./(ONQS^!$]<?^L2=)[2?LOV[O@GM.H:_5[ZTEKY?&2:/8_AZ_1U?YEU
MY!6N\Z^J=VZO\$];J0RO$</[1WS'J/;]IZ[@0/4]19?A9;;SE]F/PLF\?9C\
M+)O'V8_"R;Q]F/PLF\?9C\+)O'V9T/;M^R>YK[?7^RG)Z1J]?\(F!J'S7J&K
M5JW.!:$H>2T`\EH#M5?!'_-O:GX5\$W>W]2LK6*GT;\^HQG\#KMZY!^P'X'3
MUQ]@7]N^$C[+=J?F[X3K&KU*TGJ]+QG:AV_X?^G63,O;_P"'ZA[;V^KT%S1)
MEKZRGY+0P/):`>2T`\EH!Y+0#R6@'DM`/):`>2T`\EH#LW7_`(9ZW6@.WD]`
+/)Z`>3T`\GH#_]D_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
